e - morbidity & hospitalization410 morbidity & hospitalizationh table e.1 · 411 total...

Referencese

ctionE

Morbidity

&

hospitalization

410 Morbidity & hospitalizationh

table e.1 · 411total admission rates per 1,000 patient years: ESRD patients, by primary diagnosis,adjustedperiod prevalent patients, including all hospitalizations from part Ainstitutional inpatient claims

table e.2 · 414total admission rates per 1,000 patient years: dialysis patients, by primarydiagnosis, adjustedperiod prevalent patients, including all hospitalizations from part Ainstitutional inpatient claims

table e.3 · 417total admission rates per 1,000 patient years: hemodialysis patients, by primarydiagnosis, adjustedperiod prevalent patients, including all hospitalizations from part Ainstitutional inpatient claims

table e.4 · 420total admission rates per 1,000 patient years: CAPD/CCPD patients, by primarydiagnosis, adjustedperiod prevalent patients, including all hospitalizations from part Ainstitutional inpatient claims

table e.5 · 423total admission rates per 1,000 patient years: transplant patients, by primarydiagnosis, adjustedperiod prevalent patients, including all hospitalizations from part Ainstitutional inpatient claims

table e.6 · 426total admissions: standardized hospitalization ratios, dialysis patientsperiod prevalent patients, by state/territory

table e.7 · 427hospital days per patient year: ESRD patients, by primary diagnosis, adjustedperiod prevalent patients, including all hospitalizations from part A institu-tional inpatient claims

table e.8 · 430hospital days per patient year: dialysis patients, by primary diagnosis, adjustedperiod prevalent patients, including all hospitalizations from part A institu-tional inpatient claims

table e.9 · 433hospital days per patient year: hemodialysis patients, by primary diagnosis,adjustedperiod prevalent patients, including all hospitalizations from part A institu-tional inpatient claims

table e.10 · 436hospital days per patient year: CAPD/CCPD patients, by primary diagnosis, adjustedperiod prevalent patients, including all hospitalizations from part A institu-tional inpatient claims

table e.11 · 439hospital days per patient year: transplant patients, by primary diagnosis, adjustedperiod prevalent patients, including all hospitalizations from part A institu-tional inpatient claims

table e.12 · 442total hospital discharges: by general diagnostic related groupperiod prevalent patients

411H2004 USRDS Annual Data Report

Table E.1Total Admission Rates per 1,000 Patient Years: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,698 1,765 1,795 1,643 1,536 1,690 1,655 1,620 1,705 1,67120-29 1,728 1,656 1,667 1,620 1,599 1,586 1,616 1,602 1,628 1,64230-39 1,767 1,811 1,786 1,779 1,725 1,734 1,762 1,754 1,771 1,77740-49 1,755 1,746 1,752 1,778 1,719 1,720 1,776 1,800 1,854 1,82750-59 1,910 1,942 1,899 1,926 1,878 1,860 1,908 1,878 1,919 1,87460-64 2,003 2,016 2,031 2,049 1,979 2,016 2,031 2,004 2,009 1,99765-69 2,115 2,109 2,081 2,090 2,063 2,077 2,100 2,058 2,072 2,03270-79 2,160 2,152 2,148 2,175 2,140 2,132 2,165 2,150 2,157 2,08380+ 2,275 2,260 2,228 2,259 2,275 2,215 2,300 2,243 2,266 2,167

0-19 1,698 1,765 1,795 1,643 1,536 1,690 1,655 1,620 1,705 1,67120-44 1,753 1,759 1,759 1,757 1,702 1,705 1,736 1,728 1,767 1,77545-64 1,912 1,927 1,905 1,926 1,873 1,872 1,916 1,903 1,933 1,89565-74 2,122 2,117 2,101 2,123 2,096 2,097 2,131 2,094 2,104 2,04375+ 2,233 2,219 2,200 2,222 2,203 2,177 2,223 2,204 2,219 2,140

Male 1,902 1,910 1,871 1,879 1,843 1,844 1,878 1,848 1,869 1,825Female 2,129 2,126 2,138 2,168 2,125 2,115 2,162 2,150 2,176 2,127

White 2,072 2,055 2,048 2,055 2,021 2,018 2,047 2,021 2,028 1,977Black 1,977 2,009 1,975 2,012 1,962 1,955 2,009 1,997 2,053 2,008Native American 1,958 2,039 2,076 2,023 1,945 2,003 2,018 1,969 1,954 2,006Asian 1,293 1,299 1,320 1,352 1,382 1,353 1,432 1,420 1,390 1,364

†Hispanic 1,951 1,984 1,921 1,950 1,923†Non-Hispanic 1,974 2,017 2,001 2,025 1,974

All 2,009 2,012 1,997 2,015 1,977 1,972 2,012 1,991 2,014 1,968

DIABETES0-19 2,496 3,358 2,402 2,695 1,707 2,980 * * 1,757 81720-29 3,115 2,808 2,867 2,956 2,978 2,798 2,942 3,004 3,261 3,20930-39 2,590 2,649 2,631 2,578 2,496 2,509 2,541 2,554 2,548 2,55740-49 2,338 2,305 2,296 2,347 2,271 2,254 2,320 2,333 2,382 2,32550-59 2,283 2,314 2,256 2,310 2,235 2,235 2,286 2,244 2,253 2,18060-64 2,267 2,261 2,251 2,278 2,194 2,269 2,277 2,240 2,213 2,18865-69 2,314 2,309 2,256 2,292 2,259 2,270 2,306 2,275 2,279 2,18470-79 2,385 2,373 2,331 2,380 2,332 2,332 2,366 2,346 2,348 2,25980+ 2,556 2,430 2,432 2,498 2,558 2,481 2,578 2,497 2,527 2,361

0-19 2,491 3,363 2,405 2,700 1,707 2,983 * * 1,756 81820-44 2,560 2,546 2,556 2,566 2,464 2,453 2,506 2,486 2,551 2,54845-64 2,287 2,293 2,252 2,292 2,225 2,244 2,283 2,261 2,257 2,19665-74 2,331 2,320 2,281 2,331 2,286 2,293 2,332 2,297 2,295 2,20175+ 2,477 2,443 2,385 2,419 2,423 2,396 2,443 2,419 2,444 2,333

Male 2,282 2,282 2,204 2,238 2,180 2,195 2,233 2,209 2,204 2,125Female 2,431 2,409 2,414 2,463 2,419 2,412 2,459 2,428 2,448 2,374



All 2,360 2,349 2,314 2,356 2,305 2,309 2,352 2,324 2,332 2,256

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.1.1 & E.1.2).


Table E.1 (continued)Total Admission Rates per 1,000 Patient Years: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method uses data from the current &previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.1.1 & E.1.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,567 1,537 1,839 1,475 1,544 1,575 1,415 1,722 2,090 1,77820-29 1,718 1,651 1,542 1,465 1,416 1,367 1,398 1,304 1,358 1,42230-39 1,632 1,702 1,629 1,628 1,565 1,579 1,615 1,603 1,629 1,60640-49 1,580 1,577 1,538 1,564 1,537 1,537 1,579 1,612 1,673 1,65550-59 1,666 1,708 1,636 1,637 1,603 1,583 1,655 1,636 1,730 1,72360-64 1,769 1,820 1,841 1,848 1,788 1,792 1,788 1,805 1,845 1,85165-69 1,970 1,976 1,959 1,938 1,921 1,950 1,927 1,873 1,924 1,94570-79 2,062 2,062 2,081 2,087 2,076 2,052 2,104 2,081 2,086 2,01880+ 2,244 2,279 2,200 2,222 2,230 2,162 2,258 2,200 2,236 2,144

0-19 1,566 1,537 1,839 1,475 1,545 1,574 1,413 1,721 2,090 1,77920-44 1,617 1,645 1,577 1,582 1,543 1,545 1,566 1,565 1,606 1,61945-64 1,681 1,711 1,672 1,675 1,632 1,619 1,671 1,671 1,747 1,73165-74 1,978 2,005 1,997 1,984 1,984 1,986 2,018 1,965 2,004 1,96775+ 2,200 2,185 2,169 2,189 2,173 2,126 2,185 2,161 2,172 2,101

Male 1,816 1,834 1,785 1,780 1,765 1,752 1,783 1,745 1,789 1,757Female 2,034 2,057 2,050 2,070 2,040 2,014 2,085 2,081 2,119 2,077



All 1,910 1,930 1,899 1,905 1,883 1,865 1,913 1,890 1,931 1,895

GLOMERULONEPHRITIS0-19 1,665 1,744 1,802 1,673 1,468 1,612 1,576 1,562 1,569 1,54920-29 1,448 1,395 1,445 1,372 1,374 1,312 1,311 1,291 1,299 1,30530-39 1,381 1,422 1,373 1,359 1,319 1,322 1,316 1,292 1,285 1,31840-49 1,351 1,379 1,425 1,403 1,349 1,373 1,403 1,440 1,467 1,46650-59 1,510 1,476 1,523 1,497 1,464 1,432 1,430 1,438 1,496 1,45160-64 1,529 1,570 1,639 1,644 1,613 1,579 1,547 1,574 1,587 1,57665-69 1,743 1,716 1,716 1,694 1,694 1,686 1,679 1,587 1,625 1,67870-79 1,811 1,796 1,873 1,831 1,814 1,793 1,789 1,841 1,824 1,75280+ 1,955 1,934 2,024 1,993 2,015 2,001 2,045 2,057 2,021 1,891

0-19 1,665 1,744 1,802 1,673 1,468 1,612 1,576 1,562 1,569 1,54920-44 1,390 1,403 1,416 1,378 1,345 1,328 1,328 1,326 1,336 1,35845-64 1,468 1,464 1,504 1,491 1,453 1,448 1,457 1,472 1,508 1,47765-74 1,771 1,730 1,754 1,746 1,757 1,716 1,728 1,719 1,700 1,70375+ 1,879 1,893 2,002 1,926 1,897 1,917 1,911 1,934 1,949 1,832

Male 1,481 1,500 1,532 1,472 1,456 1,441 1,455 1,440 1,452 1,430Female 1,653 1,624 1,671 1,684 1,637 1,633 1,623 1,660 1,676 1,660

White 1,536 1,548 1,587 1,561 1,538 1,524 1,532 1,534 1,545 1,533Black 1,675 1,650 1,677 1,650 1,607 1,597 1,596 1,615 1,633 1,598Native American 1,347 1,499 1,707 1,394 1,394 1,535 1,506 1,478 1,470 1,470Asian 1,035 990 1,046 1,014 996 989 982 969 1,002 978


All 1,552 1,551 1,589 1,559 1,530 1,520 1,524 1,530 1,544 1,524


Table E.1 (continued)Total Admission Rates per 1,000 Patient Years: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.1.1 & E.1.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,710 1,767 1,785 1,627 1,564 1,716 1,688 1,629 1,751 1,72720-29 1,608 1,580 1,594 1,544 1,504 1,592 1,620 1,623 1,590 1,61130-39 1,526 1,540 1,571 1,605 1,568 1,574 1,626 1,618 1,668 1,67040-49 1,525 1,512 1,555 1,589 1,512 1,517 1,597 1,617 1,689 1,67350-59 1,551 1,618 1,590 1,620 1,611 1,561 1,606 1,566 1,602 1,57860-64 1,636 1,637 1,717 1,726 1,666 1,655 1,751 1,662 1,730 1,73765-69 1,811 1,794 1,823 1,798 1,764 1,776 1,838 1,800 1,780 1,79270-79 1,898 1,889 1,901 1,946 1,888 1,896 1,904 1,894 1,925 1,87880+ 2,058 2,088 2,071 2,097 2,065 2,032 2,086 2,044 2,049 2,041

0-19 1,710 1,767 1,785 1,628 1,564 1,716 1,688 1,628 1,751 1,72720-44 1,549 1,545 1,583 1,597 1,547 1,578 1,629 1,620 1,661 1,66045-64 1,570 1,599 1,606 1,628 1,589 1,558 1,624 1,598 1,648 1,63465-74 1,843 1,824 1,848 1,852 1,822 1,824 1,854 1,820 1,838 1,81075+ 1,983 2,000 1,996 2,041 1,972 1,974 2,010 1,997 2,003 1,985

Male 1,616 1,620 1,619 1,643 1,606 1,611 1,658 1,619 1,656 1,646Female 1,814 1,830 1,866 1,874 1,820 1,818 1,866 1,861 1,891 1,872



All 1,709 1,719 1,735 1,751 1,706 1,708 1,755 1,732 1,766 1,752


Table E.2Total Admission Rates per 1,000 Patient Years: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 2,010 2,109 2,260 1,990 1,789 1,916 1,896 1,908 2,058 2,05120-29 1,898 1,783 1,770 1,772 1,718 1,681 1,711 1,671 1,723 1,75930-39 1,940 1,940 1,935 1,947 1,886 1,884 1,902 1,890 1,908 1,91640-49 1,853 1,842 1,867 1,896 1,808 1,812 1,878 1,907 1,957 1,93250-59 1,975 2,015 1,963 2,002 1,940 1,926 1,986 1,954 1,994 1,94360-64 2,045 2,059 2,074 2,092 2,022 2,069 2,087 2,054 2,065 2,05765-69 2,132 2,127 2,096 2,110 2,083 2,100 2,129 2,089 2,103 2,06070-79 2,163 2,155 2,153 2,183 2,146 2,138 2,171 2,157 2,164 2,09280+ 2,274 2,260 2,228 2,259 2,276 2,215 2,301 2,243 2,267 2,167

0-19 2,010 2,109 2,260 1,991 1,789 1,916 1,896 1,908 2,058 2,05120-44 1,906 1,885 1,891 1,914 1,829 1,826 1,857 1,847 1,895 1,90345-64 1,975 1,991 1,974 1,999 1,937 1,941 1,993 1,975 2,004 1,96765-74 2,133 2,129 2,113 2,139 2,112 2,114 2,152 2,114 2,126 2,06475+ 2,232 2,221 2,201 2,225 2,204 2,177 2,224 2,206 2,221 2,142

Male 1,957 1,960 1,923 1,941 1,894 1,896 1,933 1,901 1,921 1,881Female 2,177 2,173 2,189 2,219 2,171 2,160 2,212 2,200 2,231 2,179



All 2,061 2,061 2,049 2,072 2,025 2,021 2,065 2,043 2,068 2,022

DIABETES0-19 3,564 * * 2,842 1,904 * * * 2,285 *20-29 3,558 3,151 3,140 3,315 3,313 3,004 3,271 3,282 3,596 3,51530-39 2,945 2,925 2,957 2,933 2,855 2,845 2,848 2,855 2,828 2,83240-49 2,489 2,449 2,481 2,527 2,425 2,400 2,483 2,495 2,523 2,46350-59 2,346 2,378 2,304 2,370 2,289 2,291 2,355 2,311 2,323 2,23660-64 2,295 2,293 2,278 2,307 2,221 2,302 2,320 2,272 2,249 2,22965-69 2,318 2,318 2,261 2,303 2,272 2,287 2,327 2,297 2,300 2,19570-79 2,383 2,371 2,332 2,383 2,339 2,336 2,372 2,346 2,351 2,26380+ 2,552 2,428 2,432 2,498 2,560 2,479 2,578 2,494 2,526 2,360

0-19 3,564 * * 2,846 1,905 * * * 2,285 *20-44 2,864 2,799 2,832 2,876 2,738 2,699 2,768 2,739 2,796 2,78145-64 2,344 2,348 2,311 2,354 2,282 2,305 2,353 2,324 2,319 2,25465-74 2,333 2,325 2,285 2,340 2,298 2,305 2,348 2,309 2,309 2,21075+ 2,473 2,441 2,384 2,419 2,424 2,395 2,445 2,419 2,444 2,332

Male 2,346 2,339 2,259 2,305 2,240 2,256 2,304 2,277 2,268 2,186Female 2,468 2,447 2,457 2,507 2,464 2,452 2,503 2,467 2,489 2,409



All 2,410 2,395 2,363 2,411 2,357 2,359 2,408 2,376 2,384 2,303

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Total Admission Rates per 1,000 Patients, & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.2.1 & E.2.2).


Table E.2 (continued)Total Admission Rates per 1,000 Patient Years: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.* Values for cells with 10 or fewer patients are suppressed.On our website: Total Admission Rates per 1,000 Patients, & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.2.1 & E.2.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,726 1,641 1,850 1,517 1,595 1,532 1,359 2,118 2,488 1,91520-29 1,756 1,666 1,553 1,542 1,423 1,373 1,403 1,280 1,361 1,45930-39 1,708 1,745 1,701 1,698 1,626 1,638 1,676 1,648 1,695 1,64540-49 1,603 1,614 1,597 1,617 1,564 1,571 1,612 1,647 1,697 1,68950-59 1,701 1,758 1,689 1,704 1,642 1,624 1,705 1,688 1,779 1,76960-64 1,805 1,860 1,878 1,880 1,821 1,841 1,827 1,844 1,892 1,89365-69 1,993 1,999 1,978 1,963 1,939 1,964 1,950 1,897 1,949 1,97970-79 2,067 2,067 2,088 2,094 2,080 2,056 2,109 2,091 2,092 2,02480+ 2,245 2,280 2,201 2,222 2,230 2,163 2,259 2,201 2,236 2,144

0-19 1,725 1,642 1,850 1,518 1,596 1,531 1,358 2,118 2,488 1,91520-44 1,669 1,687 1,633 1,650 1,579 1,592 1,610 1,601 1,655 1,66145-64 1,713 1,754 1,726 1,732 1,672 1,662 1,716 1,716 1,788 1,77365-74 1,993 2,020 2,011 2,001 1,996 1,996 2,035 1,986 2,022 1,98875+ 2,201 2,189 2,171 2,191 2,173 2,127 2,186 2,164 2,173 2,103

Male 1,835 1,853 1,812 1,812 1,783 1,772 1,804 1,768 1,807 1,778Female 2,056 2,084 2,076 2,095 2,059 2,035 2,108 2,105 2,147 2,102



All 1,931 1,953 1,926 1,934 1,902 1,886 1,935 1,913 1,954 1,918


0-19 1,756 1,882 2,121 1,865 1,635 1,671 1,621 1,620 1,601 1,73920-44 1,506 1,484 1,501 1,483 1,428 1,415 1,414 1,395 1,413 1,44245-64 1,564 1,535 1,591 1,586 1,533 1,546 1,561 1,568 1,592 1,57365-74 1,809 1,749 1,790 1,777 1,786 1,749 1,769 1,763 1,753 1,75875+ 1,888 1,890 2,007 1,931 1,896 1,919 1,913 1,931 1,953 1,839

Male 1,567 1,559 1,601 1,552 1,518 1,512 1,524 1,495 1,510 1,501Female 1,725 1,675 1,742 1,755 1,699 1,699 1,698 1,731 1,745 1,737

White 1,633 1,631 1,678 1,657 1,628 1,621 1,630 1,619 1,633 1,627Black 1,726 1,664 1,707 1,688 1,623 1,618 1,629 1,641 1,655 1,640Native American 1,438 1,518 1,755 1,447 1,511 1,648 1,519 1,523 1,516 1,551Asian 1,094 991 1,102 1,093 996 1,015 992 988 1,023 1,000


All 1,632 1,607 1,658 1,635 1,592 1,589 1,595 1,592 1,607 1,598


Table E.2 (continued)Total Admission Rates per 1,000 Patient Years: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Total Admission Rates per 1,000 Patients, & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.2.1 & E.2.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 2,114 2,197 2,327 2,051 1,858 2,016 2,018 2,004 2,237 2,19720-29 1,793 1,745 1,726 1,724 1,654 1,728 1,731 1,736 1,711 1,77130-39 1,668 1,653 1,670 1,735 1,692 1,684 1,723 1,741 1,804 1,82540-49 1,644 1,638 1,673 1,723 1,606 1,614 1,710 1,738 1,836 1,81350-59 1,650 1,747 1,703 1,736 1,715 1,667 1,727 1,682 1,726 1,70660-64 1,712 1,711 1,801 1,813 1,766 1,747 1,848 1,761 1,855 1,86765-69 1,846 1,829 1,851 1,834 1,800 1,821 1,886 1,863 1,841 1,85970-79 1,905 1,901 1,909 1,963 1,899 1,908 1,916 1,910 1,940 1,89580+ 2,054 2,090 2,066 2,098 2,066 2,034 2,087 2,045 2,052 2,044

0-19 2,114 2,197 2,327 2,051 1,858 2,016 2,018 2,003 2,237 2,19720-44 1,697 1,679 1,702 1,750 1,668 1,689 1,731 1,742 1,803 1,81445-64 1,668 1,711 1,712 1,738 1,694 1,662 1,743 1,712 1,775 1,76665-74 1,866 1,850 1,870 1,883 1,850 1,857 1,887 1,861 1,879 1,85875+ 1,981 2,005 1,993 2,047 1,976 1,976 2,012 2,002 2,008 1,989

Male 1,689 1,698 1,690 1,731 1,680 1,684 1,727 1,689 1,737 1,738Female 1,908 1,927 1,958 1,967 1,899 1,895 1,954 1,964 2,006 1,987



All 1,791 1,805 1,816 1,842 1,782 1,783 1,833 1,818 1,863 1,854


Table E.3Total Admission Rates per 1,000 Patient Years: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 2,098 1,983 2,319 2,169 1,877 1,867 1,762 2,039 2,230 2,17420-29 1,907 1,771 1,745 1,765 1,736 1,667 1,685 1,654 1,736 1,77030-39 1,938 1,957 1,918 1,928 1,874 1,863 1,917 1,875 1,920 1,91040-49 1,822 1,817 1,844 1,881 1,806 1,820 1,878 1,913 1,956 1,93750-59 1,940 1,990 1,914 1,961 1,918 1,897 1,974 1,945 1,987 1,93960-64 2,031 2,046 2,042 2,059 1,991 2,038 2,069 2,034 2,064 2,05665-69 2,123 2,120 2,071 2,091 2,055 2,087 2,121 2,093 2,097 2,05670-79 2,162 2,150 2,143 2,166 2,131 2,122 2,165 2,150 2,162 2,09780+ 2,263 2,258 2,217 2,257 2,277 2,216 2,301 2,237 2,265 2,170

0-19 2,098 1,983 2,319 2,169 1,877 1,867 1,762 2,039 2,230 2,17420-44 1,898 1,886 1,874 1,903 1,822 1,813 1,857 1,843 1,904 1,90745-64 1,947 1,968 1,934 1,964 1,918 1,921 1,982 1,965 2,000 1,96565-74 2,129 2,121 2,095 2,122 2,088 2,099 2,144 2,114 2,122 2,06575+ 2,225 2,220 2,192 2,213 2,201 2,169 2,223 2,198 2,218 2,146

Male 1,943 1,947 1,894 1,918 1,877 1,877 1,921 1,894 1,917 1,879Female 2,164 2,164 2,172 2,203 2,160 2,149 2,211 2,197 2,234 2,185



All 2,048 2,050 2,026 2,053 2,011 2,006 2,058 2,038 2,067 2,024

DIABETES0-19 4,273 * * * 1,989 * * * * *20-29 3,726 3,182 3,231 3,392 3,345 3,139 3,271 3,315 3,687 3,56730-39 2,949 2,983 2,970 2,934 2,857 2,828 2,882 2,821 2,839 2,81940-49 2,429 2,408 2,432 2,483 2,396 2,387 2,460 2,480 2,512 2,45650-59 2,270 2,314 2,227 2,302 2,240 2,243 2,327 2,289 2,304 2,21660-64 2,275 2,274 2,226 2,254 2,170 2,254 2,291 2,235 2,232 2,21565-69 2,294 2,297 2,223 2,267 2,226 2,262 2,310 2,293 2,285 2,18370-79 2,364 2,353 2,311 2,353 2,309 2,310 2,354 2,332 2,343 2,26180+ 2,510 2,418 2,428 2,494 2,558 2,471 2,569 2,487 2,519 2,355

0-19 4,273 * * * 1,990 * * * * *20-44 2,850 2,810 2,832 2,881 2,725 2,694 2,770 2,723 2,808 2,77345-64 2,291 2,302 2,243 2,290 2,234 2,262 2,325 2,295 2,299 2,23765-74 2,313 2,303 2,255 2,309 2,257 2,279 2,329 2,299 2,296 2,20275+ 2,441 2,430 2,369 2,394 2,410 2,376 2,436 2,410 2,440 2,329

Male 2,307 2,313 2,221 2,268 2,202 2,225 2,284 2,262 2,259 2,177Female 2,437 2,421 2,419 2,467 2,430 2,426 2,486 2,448 2,476 2,398



All 2,375 2,370 2,325 2,372 2,322 2,330 2,390 2,359 2,373 2,293

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Total Admission Rates per 1,000 Patients, & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.3.1 & E.3.2).


Table E.3 (continued)Total Admission Rates per 1,000 Patient Years: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,799 1,502 1,649 1,437 1,728 1,528 1,497 2,203 3,065 1,99420-29 1,704 1,630 1,495 1,491 1,430 1,333 1,404 1,253 1,317 1,42430-39 1,718 1,756 1,666 1,661 1,602 1,636 1,690 1,633 1,703 1,64640-49 1,582 1,585 1,585 1,595 1,563 1,581 1,615 1,669 1,694 1,69650-59 1,692 1,762 1,661 1,680 1,621 1,606 1,689 1,685 1,771 1,76360-64 1,787 1,833 1,855 1,860 1,801 1,814 1,820 1,843 1,895 1,91165-69 2,000 2,004 1,971 1,964 1,920 1,965 1,950 1,899 1,942 1,98170-79 2,073 2,068 2,090 2,093 2,077 2,055 2,108 2,092 2,086 2,03580+ 2,240 2,276 2,188 2,219 2,235 2,164 2,264 2,197 2,233 2,152

0-19 1,799 1,504 1,650 1,438 1,728 1,527 1,499 2,206 3,067 1,99520-44 1,666 1,680 1,608 1,623 1,564 1,586 1,614 1,602 1,651 1,66345-64 1,695 1,740 1,703 1,708 1,659 1,651 1,710 1,721 1,786 1,77665-74 1,998 2,021 2,008 2,004 1,983 1,997 2,035 1,990 2,017 1,99475+ 2,202 2,189 2,169 2,186 2,178 2,127 2,189 2,161 2,169 2,113

Male 1,834 1,849 1,793 1,797 1,776 1,763 1,798 1,765 1,801 1,778Female 2,048 2,077 2,071 2,088 2,050 2,038 2,114 2,111 2,146 2,116



All 1,926 1,948 1,913 1,922 1,894 1,882 1,934 1,914 1,950 1,924


0-19 1,617 1,616 2,014 1,876 1,549 1,634 1,497 1,644 1,742 1,85520-44 1,521 1,498 1,491 1,481 1,425 1,396 1,423 1,397 1,422 1,45945-64 1,578 1,551 1,578 1,595 1,562 1,563 1,580 1,580 1,607 1,58665-74 1,838 1,762 1,770 1,773 1,798 1,740 1,773 1,774 1,776 1,77075+ 1,892 1,886 1,993 1,933 1,889 1,912 1,914 1,919 1,950 1,857

Male 1,575 1,557 1,575 1,541 1,508 1,493 1,512 1,491 1,513 1,506Female 1,744 1,695 1,742 1,773 1,730 1,716 1,733 1,747 1,773 1,767



All 1,644 1,614 1,643 1,636 1,599 1,585 1,603 1,596 1,620 1,613


Table E.3 (continued)Total Admission Rates per 1,000 Patient Years: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 2,293 2,133 2,464 2,307 2,020 1,958 1,880 2,177 2,414 2,32720-29 1,786 1,728 1,697 1,709 1,683 1,690 1,684 1,723 1,743 1,79130-39 1,633 1,623 1,618 1,706 1,680 1,663 1,720 1,723 1,813 1,80040-49 1,607 1,634 1,674 1,726 1,617 1,624 1,709 1,748 1,849 1,83250-59 1,648 1,733 1,674 1,732 1,735 1,665 1,741 1,693 1,741 1,72860-64 1,719 1,734 1,806 1,792 1,749 1,734 1,843 1,752 1,883 1,87665-69 1,853 1,841 1,844 1,829 1,797 1,820 1,899 1,896 1,849 1,86770-79 1,931 1,916 1,908 1,950 1,897 1,893 1,924 1,905 1,952 1,90580+ 2,069 2,108 2,057 2,094 2,064 2,040 2,089 2,033 2,056 2,036

0-19 2,293 2,133 2,464 2,307 2,019 1,958 1,880 2,176 2,413 2,32620-44 1,668 1,667 1,674 1,731 1,670 1,671 1,717 1,737 1,821 1,81645-64 1,662 1,705 1,698 1,732 1,705 1,661 1,751 1,715 1,793 1,78465-74 1,884 1,863 1,868 1,874 1,847 1,849 1,898 1,879 1,892 1,87275+ 2,001 2,021 1,986 2,039 1,976 1,973 2,017 1,988 2,014 1,986

Male 1,689 1,689 1,663 1,718 1,682 1,672 1,718 1,689 1,741 1,741Female 1,913 1,935 1,968 1,977 1,913 1,890 1,959 1,976 2,041 2,007



All 1,794 1,804 1,806 1,839 1,790 1,774 1,831 1,823 1,882 1,866


Table E.4Total Admission Rates per 1,000 Patient Years: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,951 2,391 2,204 1,831 1,685 2,026 2,166 1,683 1,918 1,83020-29 1,870 1,785 1,924 1,835 1,697 1,797 1,865 1,720 1,686 1,72530-39 1,939 1,861 2,003 2,040 1,934 2,000 1,832 1,990 1,879 1,96540-49 1,946 1,947 1,949 1,966 1,790 1,767 1,872 1,841 1,940 1,89150-59 2,123 2,119 2,211 2,215 2,096 2,145 2,140 2,061 2,097 2,02460-64 2,149 2,149 2,298 2,344 2,222 2,334 2,265 2,326 2,143 2,15565-69 2,152 2,135 2,291 2,301 2,318 2,272 2,214 2,056 2,224 2,18870-79 2,199 2,205 2,237 2,369 2,305 2,336 2,217 2,230 2,211 2,02180+ 2,438 2,228 2,358 2,238 2,228 2,212 2,232 2,385 2,322 2,208

0-19 1,952 2,391 2,204 1,831 1,684 2,027 2,167 1,683 1,918 1,83120-44 1,925 1,864 1,968 1,969 1,852 1,892 1,859 1,868 1,867 1,88945-64 2,103 2,105 2,185 2,204 2,061 2,104 2,110 2,093 2,078 2,03465-74 2,162 2,170 2,266 2,321 2,337 2,294 2,229 2,119 2,211 2,09275+ 2,307 2,185 2,270 2,341 2,202 2,289 2,177 2,312 2,258 2,142

Male 2,022 2,000 2,067 2,062 1,989 2,040 2,019 1,949 1,957 1,911Female 2,266 2,228 2,337 2,394 2,300 2,300 2,243 2,302 2,302 2,195



All 2,137 2,108 2,195 2,219 2,136 2,163 2,125 2,116 2,120 2,045

DIABETES0-19 * * * * . . * * * *20-29 3,084 2,956 2,929 3,066 3,138 2,540 3,298 3,128 3,104 3,18630-39 2,932 2,695 2,826 2,900 2,827 2,920 2,647 2,992 2,777 2,93040-49 2,661 2,584 2,621 2,672 2,521 2,465 2,603 2,572 2,566 2,52350-59 2,682 2,670 2,697 2,728 2,606 2,658 2,643 2,553 2,546 2,48860-64 2,418 2,399 2,621 2,679 2,559 2,681 2,621 2,737 2,495 2,48065-69 2,437 2,407 2,573 2,618 2,640 2,582 2,496 2,332 2,506 2,43470-79 2,599 2,557 2,544 2,721 2,661 2,683 2,556 2,539 2,484 2,30380+ 3,208 2,398 2,567 2,433 2,599 2,599 2,769 2,767 2,744 2,603

0-19 * * * * . . * * * *20-44 2,883 2,694 2,778 2,823 2,749 2,717 2,723 2,806 2,713 2,83545-64 2,584 2,566 2,654 2,704 2,574 2,624 2,619 2,628 2,547 2,48265-74 2,487 2,469 2,556 2,649 2,666 2,615 2,543 2,422 2,500 2,35475+ 2,841 2,488 2,577 2,687 2,577 2,689 2,538 2,606 2,543 2,486

Male 2,547 2,448 2,433 2,491 2,470 2,510 2,483 2,395 2,340 2,293Female 2,714 2,609 2,778 2,857 2,767 2,761 2,712 2,744 2,735 2,621



All 2,635 2,533 2,614 2,683 2,625 2,642 2,603 2,578 2,547 2,465

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.“.” Zero values in this cell.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.4.1 & E.4.2).


Table E.4 (continued)Total Admission Rates per 1,000 Patient Years: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,776 2,231 2,318 1,949 1,584 1,805 * 1,972 1,592 1,72820-29 2,012 1,819 1,912 1,828 1,474 1,694 1,438 1,347 1,660 1,68630-39 1,681 1,678 1,932 1,945 1,804 1,689 1,605 1,812 1,685 1,64140-49 1,687 1,797 1,703 1,762 1,544 1,506 1,566 1,443 1,720 1,61850-59 1,741 1,722 1,871 1,874 1,777 1,787 1,875 1,736 1,880 1,82760-64 1,973 2,078 2,081 2,070 1,914 2,096 1,875 1,898 1,908 1,77665-69 1,931 1,950 2,046 2,037 2,117 2,017 1,978 1,879 2,048 2,02570-79 2,009 2,048 2,074 2,152 2,124 2,101 2,060 2,054 2,149 1,85580+ 2,319 2,339 2,367 2,234 2,118 2,154 2,068 2,212 2,237 2,024

0-19 1,776 2,232 2,316 1,945 1,581 1,792 * 1,971 1,592 1,72220-44 1,698 1,732 1,830 1,823 1,682 1,653 1,581 1,596 1,737 1,65445-64 1,819 1,850 1,892 1,916 1,744 1,765 1,780 1,685 1,815 1,75365-74 1,942 2,000 2,056 2,054 2,143 2,033 2,015 1,921 2,075 1,92475+ 2,179 2,148 2,174 2,245 2,071 2,140 2,057 2,173 2,221 1,967

Male 1,847 1,872 1,961 1,931 1,823 1,868 1,847 1,772 1,884 1,786Female 2,093 2,136 2,136 2,182 2,120 2,054 1,996 2,069 2,164 1,933

White 1,985 1,992 2,020 1,998 1,965 1,938 1,957 1,893 1,973 1,764Black 1,965 2,033 2,115 2,135 1,976 1,998 1,905 1,935 2,075 1,975Native American 1,746 2,393 2,541 2,275 2,564 2,590 1,967 1,523 1,988 1,535Asian 1,274 1,060 970 1,135 1,228 1,209 1,248 1,528 1,397 1,271


All 1,953 1,985 2,036 2,039 1,951 1,948 1,911 1,900 2,005 1,849


0-19 1,875 2,365 2,331 1,903 1,842 1,812 1,882 1,534 1,522 1,53320-44 1,427 1,424 1,556 1,500 1,450 1,516 1,397 1,389 1,404 1,37145-64 1,491 1,444 1,637 1,541 1,412 1,476 1,479 1,495 1,516 1,51365-74 1,636 1,650 1,874 1,798 1,738 1,822 1,735 1,642 1,623 1,69875+ 1,804 1,851 2,124 1,908 1,949 1,994 1,858 1,970 1,997 1,624

Male 1,503 1,522 1,704 1,568 1,542 1,615 1,565 1,485 1,507 1,468Female 1,597 1,556 1,760 1,714 1,603 1,640 1,523 1,653 1,636 1,568

White 1,522 1,561 1,712 1,630 1,589 1,637 1,573 1,561 1,533 1,470Black 1,662 1,596 1,882 1,741 1,632 1,717 1,619 1,679 1,735 1,700Native American 1,336 1,246 1,170 1,150 1,703 1,874 1,626 1,383 1,376 1,336Asian 1,075 940 1,094 1,037 860 854 792 749 849 830


All 1,541 1,536 1,727 1,628 1,567 1,625 1,548 1,554 1,560 1,509


Table E.4 (continued)Total Admission Rates per 1,000 Patient Years: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Total Admission Rates per 1,000 Patients & Counts of Rotal Admissions, Years at Risk, & Total Patients (Tables E.4.1 & E.4.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 1,997 2,396 2,157 1,804 1,630 2,133 2,281 1,715 2,085 1,95320-29 1,779 1,756 1,857 1,792 1,589 1,887 1,961 1,762 1,561 1,68230-39 1,800 1,755 1,856 1,863 1,712 1,819 1,746 1,872 1,800 1,96140-49 1,764 1,639 1,646 1,714 1,511 1,531 1,701 1,665 1,692 1,65250-59 1,636 1,792 1,806 1,750 1,615 1,691 1,653 1,620 1,613 1,53260-64 1,702 1,605 1,776 1,960 1,840 1,821 1,857 1,872 1,598 1,83265-69 1,745 1,685 1,868 1,871 1,823 1,802 1,793 1,589 1,796 1,78670-79 1,703 1,769 1,854 2,041 1,872 2,037 1,807 1,934 1,781 1,73980+ 1,820 1,863 2,074 2,106 2,019 1,872 1,982 2,342 2,008 2,341

0-19 1,997 2,397 2,158 1,804 1,630 2,134 2,282 1,715 2,084 1,95420-44 1,792 1,706 1,804 1,829 1,639 1,766 1,810 1,771 1,714 1,79045-64 1,680 1,722 1,755 1,771 1,623 1,663 1,690 1,689 1,620 1,62865-74 1,715 1,717 1,853 1,947 1,864 1,906 1,791 1,686 1,769 1,70375+ 1,772 1,820 1,954 2,069 1,874 1,973 1,883 2,205 1,895 2,094

Male 1,674 1,694 1,798 1,810 1,661 1,726 1,739 1,718 1,668 1,704Female 1,817 1,827 1,890 1,970 1,830 1,914 1,875 1,938 1,839 1,893

White 1,667 1,715 1,786 1,816 1,701 1,735 1,738 1,747 1,662 1,677Black 2,031 1,946 2,053 2,125 1,911 2,089 2,036 2,071 2,042 2,179Native American 1,541 1,813 1,731 1,766 1,617 2,224 1,953 1,978 1,710 1,823Asian 952 1,015 1,277 1,405 1,161 1,102 1,189 1,291 1,166 1,063


All 1,741 1,757 1,841 1,885 1,740 1,814 1,802 1,821 1,748 1,793


Table E.5Total Admission Rates per 1,000 Patient Years: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 971 910 1,063 959 985 1,132 1,024 1,100 1,080 1,03520-29 904 880 926 822 857 910 881 919 877 89030-39 914 993 893 907 870 861 904 886 882 93240-49 970 991 903 896 931 920 900 881 933 91750-59 1,081 1,018 1,062 1,031 1,031 976 948 960 976 94760-64 1,019 1,056 1,024 1,076 1,126 1,055 1,029 1,112 1,049 1,01265+ 1,038 1,075 1,178 1,025 991 1,016 1,110 1,025 1,126 1,109

0-19 971 910 1,063 960 985 1,131 1,024 1,100 1,080 1,03520-44 930 952 923 890 904 899 896 888 876 91345-64 1,068 1,069 1,009 1,008 1,017 978 964 983 1,004 96565+ 1,035 1,073 1,174 1,024 991 1,015 1,109 1,023 1,124 1,108

Male 1,005 1,024 1,018 951 962 950 937 925 957 942Female 1,039 1,056 1,143 1,052 1,023 1,027 1,119 1,063 1,135 1,120

White 1,007 996 1,017 942 929 948 966 944 998 981Black 1,059 1,121 1,195 1,110 1,122 1,068 1,119 1,093 1,129 1,132Other race 920 953 939 862 769 857 1,010 798 907 789

†Hispanic 1,008 921 970 1,000 959†Non-Hispanic 963 1,013 972 1,027 1,013

All 1,021 1,039 1,077 999 991 987 1,023 990 1,041 1,026

DIABETES0-19 * * * * * * * * * *20-29 1,642 1,494 1,654 1,533 1,616 1,732 1,528 1,623 1,534 1,79130-39 1,487 1,617 1,438 1,425 1,333 1,320 1,409 1,386 1,345 1,40640-49 1,411 1,445 1,305 1,253 1,243 1,237 1,221 1,168 1,238 1,23150-59 1,350 1,318 1,368 1,342 1,272 1,231 1,219 1,211 1,180 1,14060-64 1,176 1,215 1,216 1,255 1,300 1,238 1,208 1,298 1,181 1,11565+ 1,322 1,255 1,395 1,209 1,049 1,089 1,212 1,235 1,331 1,323

0-19 * * * * * * * * * *20-44 1,471 1,505 1,441 1,400 1,368 1,368 1,367 1,321 1,311 1,38645-64 1,350 1,385 1,306 1,287 1,245 1,210 1,211 1,226 1,201 1,15265+ 1,315 1,251 1,390 1,209 1,049 1,087 1,211 1,232 1,327 1,320

Male 1,320 1,290 1,319 1,261 1,198 1,162 1,117 1,180 1,153 1,157Female 1,332 1,306 1,399 1,255 1,132 1,171 1,323 1,297 1,384 1,348

White 1,333 1,269 1,312 1,225 1,137 1,162 1,151 1,205 1,245 1,242Black 1,329 1,350 1,467 1,335 1,241 1,194 1,356 1,332 1,358 1,329Other race 1,252 1,303 1,252 1,151 983 1,069 1,223 1,096 1,095 1,002


All 1,327 1,298 1,361 1,258 1,163 1,167 1,225 1,241 1,274 1,257



Table E.5 (continued)Total Admission Rates per 1,000 Patient Years: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with fewer than 10 patients are suppressed.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.5.1 & E.5.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 906 814 1,399 941 1,295 1,215 1,118 1,057 750 *20-29 1,087 956 992 814 951 873 798 774 765 73930-39 841 876 770 814 862 796 828 815 800 92440-49 914 876 756 820 923 897 846 814 902 86550-59 971 792 840 756 925 843 771 806 861 86060-64 912 977 891 972 1,025 897 852 962 957 98865+ 842 978 1,059 924 1,025 1,063 1,110 865 1,011 974

0-19 904 811 1,391 941 1,293 1,210 1,115 1,052 749 *20-44 913 870 834 806 928 844 803 794 788 86445-64 952 872 803 819 920 871 825 848 917 89265+ 842 976 1,056 923 1,024 1,062 1,109 864 1,010 974

Male 924 963 922 828 942 957 927 797 927 878Female 822 887 1,004 951 1,045 1,003 1,059 927 989 1,016

White 857 889 875 789 881 934 958 789 917 845Black 927 996 1,058 984 1,117 1,031 1,009 943 1,000 1,054Other race 569 613 745 757 684 838 990 521 817 639

†Hispanic 735 745 589 721 693†Non-Hispanic 969 983 850 955 928

All 880 930 957 881 986 977 984 853 953 937

GLOMERULONEPHRITIS0-19 1,021 1,067 1,070 1,085 988 1,157 1,014 1,227 1,111 1,00920-29 763 761 820 722 753 773 759 818 754 75630-39 669 753 634 648 603 585 568 634 651 68140-49 649 744 676 617 684 645 603 656 698 66350-59 789 758 821 804 757 641 620 695 735 69960-64 810 694 658 780 914 731 703 774 815 73665+ 871 950 919 924 856 775 894 895 900 842

0-19 1,022 1,068 1,069 1,083 989 1,159 1,014 1,227 1,112 1,01020-44 697 749 716 664 669 658 628 686 677 69545-64 742 747 717 732 769 664 645 708 758 69965+ 873 953 921 923 857 777 895 896 901 844

Male 722 780 733 712 715 644 670 740 722 692Female 839 863 861 865 830 781 780 797 858 820

White 735 758 732 731 698 641 684 723 727 722Black 883 975 955 930 940 857 799 910 911 839Other race 548 547 468 424 502 487 599 419 600 499


All 770 814 786 775 762 700 715 763 777 745


Table E.5 (continued)Total Admission Rates per 1,000 Patient Years: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Total Admission Rates per 1,000 Patients & Counts of Total Admissions, Years at Risk, & Total Patients (Tables E.5.1 & E.5.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 957 852 1,042 899 974 1,122 1,032 1,055 1,081 1,05820-29 756 790 797 723 707 827 848 878 855 82830-39 707 774 766 776 727 776 844 749 766 76540-49 721 732 734 746 736 757 786 768 764 77350-59 734 729 743 757 741 727 714 702 772 73660-64 709 781 706 724 744 793 811 829 822 81465+ 760 852 960 786 828 836 935 852 918 940

0-19 957 851 1,042 899 974 1,121 1,032 1,056 1,081 1,05820-44 724 761 768 756 730 788 839 800 780 77145-64 726 744 727 740 732 744 738 733 787 76765+ 760 852 961 786 828 836 934 853 919 939

Male 740 790 801 728 723 755 805 776 799 813Female 751 802 887 814 841 858 909 845 902 889

White 724 745 789 705 731 747 799 755 789 792Black 811 948 1,007 974 952 988 1,013 983 1,020 1,036Other race 680 668 658 503 452 568 765 580 728 589


All 745 796 842 768 779 803 854 809 847 848


Table E.6Total Admissions: Standardized Hospitalization Ratios, Adjusted: Dialysis Patientsperiod prevalent patients, by state/territory

Adjusted for age, gender, race, primary cause of renal failure, & vintage.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.

2000-2002 2000 2001 2002Alabama 1.00 1.02 0.99 1.00Alaska 0.69 0.70 0.78 0.66Arizona 0.96 0.94 0.94 0.96Arkansas 1.15 1.17 1.15 1.14California 0.94 0.94 0.92 0.94Colorado 0.86 0.83 0.88 0.88Connecticut 0.93 0.91 0.93 0.95Delaware 0.79 0.81 0.79 0.79District of Columbia 1.18 1.21 1.23 1.13Florida 1.06 1.04 1.06 1.07Georgia 0.97 1.00 0.99 0.96Hawaii 0.90 0.91 0.87 0.92Idaho 0.82 0.85 0.85 0.76Illinois 1.13 1.14 1.17 1.12Indiana 0.97 0.96 0.97 0.99Iowa 0.87 0.89 0.84 0.90Kansas 1.02 1.07 1.00 0.98Kentucky 1.00 0.99 0.98 1.02Louisiana 1.24 1.27 1.25 1.22Maine 0.91 0.88 0.96 0.87Maryland 1.10 1.11 1.06 1.16Massachusetts 1.19 1.18 1.19 1.19Michigan 1.04 0.98 1.05 1.08Minnesota 0.99 0.97 0.97 1.00Mississippi 0.89 0.92 0.89 0.87Missouri 1.06 1.05 1.08 1.06Montana 0.73 0.72 0.76 0.69Nebraska 0.88 0.93 0.86 0.84Nevada 0.98 0.96 0.91 1.05New Hampshire 0.95 1.00 0.95 0.89New Jersey 1.05 1.06 1.04 1.04New Mexico 0.84 0.78 0.85 0.82New York 0.92 0.93 0.92 0.92North Carolina 1.01 1.04 1.02 0.98North Dakota 0.81 0.88 0.83 0.73Ohio 1.03 1.03 1.04 1.03Oklahoma 1.07 1.06 1.09 1.06Oregon 0.89 0.90 0.88 0.91Pennsylvania 1.12 1.10 1.13 1.14Rhode Island 0.98 1.01 1.01 0.93South Carolina 0.95 0.97 0.94 0.95South Dakota 0.88 0.87 0.90 0.86Tennessee 0.97 0.95 0.99 0.97Texas 0.99 0.98 0.98 1.01Utah 0.71 0.74 0.68 0.74Vermont 0.78 0.80 0.81 0.77Virginia 0.90 0.90 0.91 0.90Washington 0.86 0.86 0.87 0.85West Virginia 1.11 1.12 1.07 1.10Wisconsin 0.89 0.92 0.89 0.89Wyoming 0.65 0.66 0.71 0.62

American Samoa 0.53 0.76 0.64 0.51Guam 0.92 0.84 1.03 0.88Saipan 1.35 1.09 1.11 1.49Puerto Rico 1.05 1.05 1.05 1.04Virgin Islands 0.75 0.95 0.74 0.71

All 1.00 1.00 1.00 1.00


Table E.7Hospital Days per Patient Year: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 12.6 12.7 11.6 10.2 9.9 10.5 9.7 9.9 10.2 10.020-29 12.0 10.9 10.4 9.7 9.2 9.4 9.1 8.9 9.4 9.430-39 13.2 12.9 11.8 11.3 10.8 10.5 10.9 10.7 10.9 10.840-49 14.0 13.3 12.5 12.1 11.5 11.4 12.0 11.8 12.3 12.050-59 16.0 15.5 14.5 14.1 13.5 13.3 13.7 13.6 14.0 13.560-64 17.1 16.5 15.7 15.4 14.6 14.9 15.2 15.0 15.2 15.165-69 18.4 17.4 16.7 15.8 15.6 15.7 16.0 15.7 15.7 15.470-79 18.7 17.6 16.7 16.2 16.0 15.8 16.2 16.3 16.4 15.780+ 19.0 17.9 16.9 16.4 16.5 16.0 16.9 16.3 16.3 15.6

0-19 12.6 12.7 11.6 10.2 9.9 10.5 9.7 9.9 10.2 10.020-44 13.1 12.6 11.8 11.3 10.7 10.6 10.8 10.5 10.9 10.945-64 16.0 15.4 14.4 14.0 13.4 13.4 13.8 13.7 14.1 13.765-74 18.5 17.4 16.6 16.0 15.8 15.8 16.1 16.0 16.0 15.575+ 18.8 17.8 16.8 16.5 16.3 15.9 16.6 16.3 16.4 15.7

Male 15.6 15.0 13.9 13.4 13.0 12.9 13.3 13.1 13.2 12.8Female 18.1 17.1 16.4 15.9 15.6 15.4 15.9 15.7 16.0 15.6

White 17.3 16.3 15.5 14.9 14.6 14.5 14.7 14.5 14.6 14.1Black 16.6 15.9 14.9 14.5 14.0 13.9 14.6 14.3 14.9 14.6Native American 14.7 15.2 13.8 13.8 13.3 13.0 13.9 13.6 13.2 13.8Asian 10.8 10.8 10.6 11.0 11.0 10.4 10.9 11.4 11.4 10.7

†Hispanic 13.6 14.1 13.6 14.0 13.9†Non-Hispanic 14.2 14.6 14.5 14.7 14.2

All 16.8 16.0 15.1 14.6 14.2 14.1 14.5 14.3 14.6 14.1

DIABETES0-19 21.0 24.9 13.0 21.1 12.4 29.0 * * 15.2 5.220-29 23.8 20.0 19.0 19.1 18.5 17.9 18.6 18.0 20.8 20.430-39 20.8 20.2 18.7 17.4 16.8 16.2 16.8 16.6 17.2 16.940-49 19.7 18.6 17.3 17.2 16.1 15.7 16.4 16.4 16.9 16.650-59 19.5 18.9 17.5 17.5 16.5 16.4 16.9 16.6 17.1 16.260-64 19.8 18.9 17.7 17.5 16.3 17.1 17.3 17.1 17.1 16.865-69 20.6 19.2 18.3 17.9 17.6 17.6 18.0 17.8 17.8 17.170-79 21.3 19.9 18.6 18.2 17.9 17.8 18.2 18.4 18.5 17.780+ 22.4 19.7 19.4 18.9 19.0 18.5 19.7 18.8 18.9 17.9

0-19 21.0 24.9 13.0 21.2 12.4 29.0 * * 15.2 5.220-44 20.7 19.7 18.5 17.9 16.8 16.3 16.9 16.3 17.2 17.145-64 19.7 18.8 17.5 17.3 16.3 16.5 16.9 16.9 17.1 16.465-74 20.9 19.4 18.4 18.0 17.7 17.7 18.0 18.0 18.0 17.375+ 21.6 20.1 18.9 18.5 18.3 18.0 18.9 18.5 18.8 18.0

Male 19.7 18.7 17.3 17.0 16.2 16.2 16.7 16.5 16.6 15.9Female 21.3 19.9 19.0 18.6 18.2 18.0 18.6 18.4 18.8 18.2



All 20.5 19.3 18.2 17.8 17.2 17.2 17.7 17.5 17.8 17.1

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Hospital Days per Patient & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.7.1 & E.7.2).


Table E.7 (continued)Hospital Days per Patient Year: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Hospital Days per Patient & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.7.1 & E.7.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 10.2 12.0 12.2 10.4 8.9 8.6 7.1 9.0 12.0 8.720-29 10.9 10.1 9.1 8.0 7.5 7.2 6.7 6.6 7.0 7.430-39 11.2 11.2 9.6 9.2 8.7 8.5 8.7 9.0 9.1 8.740-49 11.6 11.0 10.1 9.6 9.4 9.4 9.8 9.5 10.0 9.850-59 13.1 12.8 11.7 10.9 10.7 10.6 11.2 11.0 11.8 11.860-64 14.0 14.1 13.2 12.9 12.8 12.7 12.8 12.9 13.3 13.665-69 16.0 15.7 15.0 13.6 13.8 14.0 13.8 13.5 13.9 14.070-79 16.8 16.0 15.2 14.8 15.1 14.6 15.1 15.0 15.2 14.680+ 18.0 17.6 16.0 15.6 15.7 15.3 16.2 15.4 15.7 14.9

0-19 10.2 12.1 12.2 10.4 8.9 8.6 7.1 9.0 12.0 8.720-44 11.1 10.9 9.7 9.1 8.8 8.7 8.7 8.7 8.9 9.045-64 13.1 12.9 11.8 11.1 11.0 10.8 11.3 11.3 11.9 11.865-74 16.1 15.7 14.9 13.9 14.3 14.2 14.5 14.2 14.6 14.275+ 17.7 16.8 15.8 15.5 15.6 15.1 15.6 15.4 15.5 14.9

Male 14.0 13.6 12.4 11.8 11.9 11.6 11.9 11.8 12.0 11.8Female 16.5 15.9 15.0 14.4 14.4 14.2 14.9 14.5 15.0 14.6



All 15.0 14.6 13.5 13.0 13.0 12.8 13.2 13.0 13.3 13.0

GLOMERULONEPHRITIS0-19 12.2 12.3 11.0 10.0 9.0 9.2 8.8 9.4 9.3 9.220-29 9.5 8.5 9.0 8.0 7.6 7.3 7.0 7.0 6.9 6.830-39 9.6 9.2 8.3 8.1 7.9 7.6 7.8 7.4 7.5 7.540-49 9.9 9.7 9.8 9.1 8.7 8.6 9.0 9.0 9.3 8.950-59 11.7 11.3 11.1 10.5 10.3 10.0 10.0 9.9 10.3 10.060-64 12.7 12.0 12.8 11.7 11.8 11.2 11.1 10.8 11.5 11.465-69 14.2 13.4 13.4 12.4 12.1 12.0 12.2 11.4 11.5 11.670-79 14.9 14.1 14.1 13.1 13.3 12.8 13.1 13.1 13.1 12.480+ 16.0 15.2 15.4 14.3 14.5 13.9 14.7 14.6 13.9 13.0

0-19 12.2 12.3 11.0 10.0 9.0 9.2 8.8 9.4 9.3 9.220-44 9.6 9.1 9.0 8.3 8.0 7.7 7.8 7.6 7.7 7.745-64 11.4 11.0 10.9 10.4 10.1 9.9 10.0 9.9 10.4 10.065-74 14.6 13.6 13.5 12.6 12.7 12.2 12.4 12.3 12.1 12.075+ 15.3 14.8 14.9 13.9 13.8 13.5 14.0 13.7 13.8 12.7

Male 11.1 10.7 10.6 9.8 9.8 9.4 9.6 9.4 9.5 9.1Female 13.0 12.2 12.2 11.6 11.1 11.0 11.1 11.1 11.3 11.0



All 11.9 11.3 11.3 10.5 10.3 10.0 10.2 10.1 10.2 9.9


Table E.7 (continued)Hospital Days per Patient Year: ESRD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 12.8 12.7 11.8 10.2 10.3 10.9 10.1 10.0 10.4 10.520-29 11.6 10.8 9.9 9.2 8.7 9.8 9.5 9.1 9.4 9.530-39 11.8 11.5 11.0 10.6 10.2 9.9 10.4 9.9 10.1 10.340-49 12.8 11.8 11.3 11.0 10.3 10.5 11.1 10.8 11.4 11.050-59 13.6 13.4 12.7 12.0 11.8 11.5 11.6 11.5 11.6 11.360-64 14.4 13.9 13.5 13.2 12.7 12.4 13.1 12.4 12.8 12.865-69 16.3 15.4 15.2 13.9 13.2 13.4 14.1 13.7 13.0 13.070-79 17.1 16.3 15.6 15.1 14.2 14.3 14.5 14.6 14.4 13.980+ 17.8 16.9 16.3 15.7 15.3 15.1 15.4 15.3 14.9 14.9

0-19 12.8 12.7 11.8 10.2 10.3 10.9 10.1 10.0 10.4 10.520-44 11.9 11.3 10.8 10.3 9.8 10.1 10.4 9.9 10.3 10.245-64 13.7 13.3 12.5 12.1 11.6 11.4 11.7 11.5 11.8 11.665-74 16.7 15.7 15.3 14.4 13.7 13.9 14.1 14.0 13.7 13.375+ 17.4 16.8 16.0 15.6 14.8 14.6 15.2 15.1 14.7 14.5

Male 13.6 13.1 12.3 11.9 11.2 11.4 11.6 11.4 11.5 11.3Female 15.7 15.0 14.5 13.8 13.4 13.2 13.6 13.4 13.4 13.3



All 14.6 14.0 13.4 12.8 12.2 12.2 12.6 12.3 12.4 12.2


Table E.8Hospital Days per Patient Year: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 13.6 13.8 13.9 11.6 11.4 11.6 10.2 11.5 11.4 11.420-29 12.2 11.0 10.3 10.3 9.4 9.6 9.4 9.1 9.6 9.830-39 13.7 13.2 12.5 12.1 11.7 11.3 11.6 11.2 11.5 11.540-49 14.2 13.5 12.9 12.6 11.8 12.0 12.5 12.3 12.8 12.650-59 16.1 15.8 14.7 14.5 13.8 13.7 14.2 14.0 14.5 13.960-64 17.3 16.7 15.9 15.6 14.9 15.2 15.6 15.3 15.5 15.465-69 18.4 17.4 16.7 15.9 15.7 15.8 16.2 15.9 15.8 15.570-79 18.7 17.6 16.7 16.3 16.1 15.8 16.3 16.3 16.4 15.880+ 19.0 17.9 16.9 16.4 16.5 16.0 16.9 16.3 16.3 15.6

0-19 13.6 13.8 13.9 11.6 11.4 11.6 10.2 11.4 11.4 11.420-44 13.5 12.8 12.2 12.0 11.3 11.2 11.4 11.0 11.4 11.545-64 16.2 15.6 14.7 14.4 13.7 13.8 14.3 14.1 14.5 14.165-74 18.5 17.5 16.7 16.0 15.9 15.8 16.2 16.1 16.1 15.675+ 18.8 17.8 16.8 16.5 16.3 15.9 16.6 16.3 16.3 15.7

Male 15.7 15.1 14.0 13.7 13.2 13.2 13.5 13.3 13.5 13.1Female 18.3 17.3 16.6 16.1 15.8 15.7 16.2 16.0 16.3 15.9



All 16.9 16.1 15.3 14.9 14.4 14.4 14.8 14.6 14.8 14.4

DIABETES0-19 27.5 * * 22.8 13.3 * * * 19.1 *20-29 25.8 21.2 19.7 21.1 19.6 18.8 20.1 19.4 21.7 21.730-39 22.3 21.2 20.4 19.5 18.9 18.2 18.6 17.9 18.5 18.440-49 20.2 19.2 18.2 18.0 16.8 16.5 17.4 17.3 17.7 17.550-59 19.8 19.2 17.6 17.9 16.7 16.7 17.3 17.0 17.6 16.560-64 19.9 19.0 17.8 17.7 16.5 17.3 17.6 17.3 17.3 17.165-69 20.6 19.2 18.3 17.9 17.6 17.7 18.1 17.9 17.9 17.270-79 21.2 19.9 18.6 18.3 17.9 17.8 18.3 18.4 18.5 17.780+ 22.4 19.7 19.4 18.9 19.0 18.5 19.7 18.8 18.9 17.9

0-19 27.6 * * 22.8 13.3 * * * 19.1 *20-44 22.0 20.7 19.8 19.7 18.2 17.7 18.4 17.6 18.3 18.445-64 19.9 19.0 17.7 17.6 16.6 16.8 17.4 17.2 17.5 16.865-74 20.8 19.4 18.4 18.0 17.7 17.8 18.1 18.1 18.1 17.375+ 21.6 20.0 18.9 18.5 18.3 18.0 18.9 18.5 18.8 18.0

Male 19.9 18.9 17.4 17.4 16.4 16.5 17.1 16.9 16.9 16.2Female 21.5 20.0 19.2 18.8 18.4 18.3 18.9 18.6 19.1 18.4



All 20.7 19.5 18.4 18.1 17.4 17.5 18.0 17.8 18.0 17.4



Table E.8 (continued)Hospital Days per Patient Year: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 9.6 12.9 11.6 10.3 9.2 8.9 5.9 10.3 12.9 8.420-29 9.8 9.3 8.2 8.0 7.1 6.8 6.4 6.3 6.6 7.430-39 11.0 10.9 9.8 9.3 8.8 8.6 8.8 9.1 9.2 8.840-49 11.2 10.8 10.2 9.6 9.3 9.5 9.9 9.5 9.9 9.950-59 12.9 12.9 11.8 11.2 10.8 10.7 11.4 11.2 12.0 12.060-64 14.1 14.2 13.3 12.9 12.9 12.9 13.0 13.2 13.5 13.765-69 16.1 15.8 15.0 13.7 13.9 14.1 13.9 13.6 14.0 14.270-79 16.8 16.0 15.2 14.8 15.1 14.6 15.1 15.1 15.2 14.680+ 18.0 17.6 16.0 15.6 15.7 15.3 16.2 15.4 15.7 14.9

0-19 9.6 12.9 11.6 10.3 9.2 8.9 5.9 10.3 12.9 8.420-44 10.8 10.6 9.7 9.2 8.7 8.8 8.7 8.7 8.9 9.045-64 13.0 12.9 11.9 11.3 11.1 11.0 11.6 11.4 12.0 12.065-74 16.2 15.8 15.0 14.0 14.3 14.2 14.5 14.3 14.7 14.375+ 17.7 16.9 15.8 15.5 15.6 15.1 15.6 15.4 15.5 14.9

Male 13.8 13.5 12.4 11.9 11.9 11.7 11.9 11.9 12.0 11.9Female 16.5 16.0 15.1 14.5 14.5 14.3 15.0 14.7 15.1 14.7



All 15.0 14.6 13.6 13.0 13.0 12.8 13.3 13.1 13.4 13.1


0-19 11.7 12.2 11.8 10.0 9.6 9.0 8.0 9.0 8.5 9.420-44 9.6 9.1 9.0 8.7 8.2 8.1 8.2 7.7 8.0 8.145-64 11.5 11.0 11.2 10.8 10.5 10.4 10.7 10.4 10.8 10.665-74 14.8 13.6 13.7 12.7 12.8 12.3 12.7 12.6 12.5 12.475+ 15.4 14.8 15.0 13.9 13.8 13.5 14.0 13.7 13.8 12.7

Male 11.1 10.6 10.7 10.1 9.9 9.6 9.9 9.5 9.6 9.4Female 13.1 12.2 12.4 11.9 11.4 11.3 11.6 11.4 11.7 11.5



All 11.9 11.3 11.4 10.8 10.5 10.3 10.6 10.3 10.5 10.3


Table E.8 (continued)Hospital Days per Patient Year: Dialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 14.4 14.3 14.8 12.2 12.2 12.6 11.2 12.5 12.6 12.420-29 12.2 11.4 9.9 10.0 9.3 10.3 9.9 9.6 10.0 10.330-39 12.2 11.8 11.5 11.3 10.9 10.6 10.8 10.5 10.7 11.240-49 13.4 12.4 11.9 11.7 10.9 11.2 11.8 11.6 12.3 12.050-59 14.0 14.0 13.2 12.6 12.3 12.1 12.4 12.3 12.5 12.260-64 14.8 14.4 14.0 13.7 13.4 13.0 13.8 13.1 13.6 13.765-69 16.5 15.5 15.2 14.1 13.4 13.6 14.3 14.1 13.3 13.570-79 17.1 16.4 15.6 15.2 14.3 14.4 14.5 14.7 14.5 14.080+ 17.8 16.9 16.2 15.7 15.3 15.1 15.4 15.4 15.0 15.0

0-19 14.4 14.3 14.8 12.2 12.2 12.6 11.2 12.5 12.5 12.420-44 12.3 11.8 11.3 11.1 10.5 10.8 11.0 10.6 11.1 11.145-64 14.3 13.8 13.1 12.6 12.2 12.1 12.5 12.3 12.7 12.665-74 16.8 15.8 15.3 14.5 13.8 14.1 14.3 14.3 13.9 13.775+ 17.4 16.8 16.0 15.7 14.8 14.6 15.1 15.1 14.7 14.6

Male 13.8 13.3 12.5 12.3 11.6 11.7 11.9 11.8 11.9 11.8Female 16.2 15.4 15.0 14.3 13.9 13.8 14.2 14.1 14.1 14.0



All 14.9 14.3 13.7 13.2 12.6 12.7 13.0 12.9 12.9 12.8


Table E.9Hospital Days Per Patient Year: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 13.1 11.4 13.2 11.2 10.7 10.0 9.0 11.3 10.4 11.320-29 12.1 10.7 9.9 9.9 9.3 9.1 9.1 8.8 9.4 9.730-39 13.3 12.9 12.1 11.7 11.3 11.0 11.4 10.9 11.3 11.340-49 13.5 13.0 12.3 12.0 11.4 11.8 12.4 12.1 12.5 12.550-59 15.4 15.2 14.0 13.7 13.3 13.1 13.9 13.7 14.2 13.760-64 16.8 16.2 15.2 14.9 14.3 14.7 15.3 15.0 15.3 15.265-69 17.8 16.9 16.1 15.4 15.2 15.5 15.9 15.7 15.6 15.370-79 18.2 17.1 16.3 15.8 15.7 15.5 16.0 16.1 16.2 15.780+ 18.5 17.6 16.6 16.2 16.3 15.9 16.8 16.1 16.2 15.5

0-19 13.1 11.4 13.2 11.2 10.7 10.0 9.0 11.3 10.4 11.320-44 13.1 12.6 11.8 11.6 10.9 10.8 11.3 10.8 11.3 11.445-64 15.5 15.0 14.0 13.7 13.3 13.3 14.0 13.8 14.2 13.965-74 18.0 16.9 16.1 15.5 15.4 15.5 15.9 15.9 15.9 15.575+ 18.3 17.4 16.5 16.1 16.0 15.7 16.4 16.1 16.2 15.6

Male 15.1 14.6 13.5 13.2 12.8 12.8 13.3 13.1 13.3 13.0Female 17.7 16.7 16.1 15.6 15.3 15.3 16.0 15.7 16.1 15.7



All 16.4 15.6 14.7 14.3 14.0 14.0 14.6 14.4 14.6 14.3

DIABETES0-19 31.4 * * * 14.1 * * * * *20-29 26.5 21.7 19.9 21.9 20.1 19.5 20.3 19.8 21.9 22.130-39 21.9 20.8 19.8 19.1 18.3 17.9 18.4 17.5 18.4 18.240-49 18.9 18.4 17.2 17.0 16.0 16.2 17.1 16.9 17.3 17.350-59 18.6 18.1 16.7 16.9 16.1 16.0 16.9 16.6 17.2 16.260-64 19.3 18.4 17.0 16.8 15.8 16.7 17.3 16.9 17.0 16.865-69 19.7 18.6 17.6 17.2 16.9 17.2 17.7 17.6 17.5 16.970-79 20.5 19.2 18.0 17.6 17.4 17.4 17.9 18.1 18.3 17.680+ 21.2 19.4 19.0 18.7 18.8 18.3 19.5 18.6 18.7 17.7

0-19 31.4 * * * 14.1 * * * * *20-44 21.3 20.4 19.1 19.3 17.7 17.4 18.3 17.2 18.2 18.345-64 18.9 18.1 16.7 16.7 15.9 16.2 17.0 16.8 17.1 16.565-74 20.1 18.7 17.7 17.3 17.1 17.3 17.7 17.8 17.8 17.175+ 20.7 19.6 18.5 18.1 18.0 17.7 18.7 18.3 18.6 17.8

Male 19.0 18.3 16.8 16.7 15.9 16.1 16.8 16.6 16.7 16.0Female 20.6 19.3 18.4 18.1 17.8 17.8 18.5 18.3 18.7 18.1



All 19.8 18.8 17.6 17.4 16.9 17.0 17.7 17.5 17.7 17.1



Table E.9 (continued)Hospital Days Per Patient Year: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 9.0 6.5 7.7 9.0 9.5 10.6 6.5 11.5 15.6 9.420-29 9.3 9.0 7.7 7.2 7.0 6.3 6.3 6.1 6.2 7.130-39 10.8 10.7 9.4 8.9 8.2 8.4 8.6 8.8 9.1 8.740-49 10.8 10.2 9.6 9.1 9.0 9.3 9.6 9.4 9.6 9.950-59 12.8 12.7 11.4 10.7 10.3 10.2 11.2 11.1 11.8 11.860-64 13.8 13.6 12.8 12.5 12.4 12.5 12.8 13.0 13.4 13.765-69 15.6 15.3 14.6 13.3 13.5 13.8 13.7 13.5 13.8 14.270-79 16.4 15.5 14.9 14.5 14.8 14.3 14.9 15.0 14.9 14.680+ 17.5 17.3 15.7 15.5 15.6 15.2 16.1 15.3 15.6 14.9

0-19 9.0 6.5 7.7 9.0 9.5 10.6 6.5 11.6 15.6 9.420-44 10.6 10.3 9.3 8.7 8.3 8.5 8.5 8.5 8.7 9.045-64 12.7 12.4 11.4 10.9 10.7 10.6 11.4 11.3 11.8 11.965-74 15.8 15.4 14.5 13.7 14.0 13.9 14.3 14.2 14.5 14.375+ 17.3 16.5 15.5 15.3 15.4 14.9 15.5 15.3 15.3 14.9

Male 13.6 13.2 12.0 11.6 11.6 11.4 11.7 11.7 11.9 11.8Female 16.0 15.5 14.7 14.2 14.1 14.1 14.8 14.5 14.9 14.7



All 14.6 14.2 13.2 12.7 12.7 12.5 13.1 12.9 13.2 13.0


0-19 10.6 9.7 10.2 9.5 8.0 8.6 7.1 8.3 7.4 8.420-44 9.4 9.0 8.7 8.2 7.9 7.6 8.1 7.6 7.7 7.945-64 11.3 10.8 10.6 10.4 10.3 10.1 10.5 10.2 10.7 10.465-74 14.4 13.3 13.0 12.2 12.7 12.0 12.5 12.3 12.4 12.275+ 14.8 14.4 14.5 13.6 13.5 13.3 13.9 13.5 13.6 12.7

Male 10.8 10.4 10.2 9.6 9.6 9.3 9.6 9.2 9.4 9.2Female 12.8 12.1 11.9 11.5 11.3 11.1 11.5 11.2 11.5 11.3



All 11.6 11.1 10.9 10.4 10.3 10.0 10.4 10.1 10.3 10.1


Table E.9 (continued)Hospital Days Per Patient Year: Hemodialysis Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims


OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 14.1 12.2 14.7 11.9 11.8 10.5 9.7 12.4 11.5 12.620-29 12.0 11.0 9.5 9.7 9.3 9.6 9.4 9.1 9.9 10.330-39 11.6 11.3 11.2 11.1 10.5 10.3 10.5 10.2 10.6 10.940-49 12.7 12.0 11.6 11.3 10.7 11.0 11.8 11.4 12.1 11.950-59 13.6 13.5 12.7 12.1 12.0 11.8 12.2 12.1 12.4 12.160-64 14.6 14.2 13.5 13.2 12.9 12.3 13.6 12.9 13.6 13.565-69 16.2 15.3 14.9 13.7 13.2 13.5 14.3 14.3 13.3 13.370-79 17.0 16.2 15.3 14.8 13.9 14.1 14.5 14.5 14.4 13.980+ 17.8 16.7 15.9 15.4 15.0 15.0 15.3 15.2 14.9 14.8

0-19 14.1 12.2 14.7 11.9 11.8 10.5 9.7 12.4 11.5 12.620-44 11.8 11.4 10.9 10.9 10.3 10.3 10.7 10.3 11.0 11.145-64 13.8 13.4 12.6 12.1 11.9 11.7 12.4 12.1 12.5 12.465-74 16.6 15.5 15.1 14.1 13.6 13.8 14.3 14.3 13.9 13.675+ 17.3 16.7 15.6 15.3 14.5 14.4 15.0 14.9 14.7 14.4

Male 13.5 13.0 12.1 11.8 11.3 11.4 11.7 11.6 11.8 11.7Female 15.9 15.0 14.7 14.0 13.6 13.4 14.0 13.9 14.0 13.9



All 14.6 13.9 13.4 12.8 12.4 12.3 12.8 12.7 12.8 12.7


Table E.10Hospital Days Per Patient Year: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 13.9 16.2 14.6 12.2 12.4 13.5 12.5 10.9 13.1 11.820-29 12.5 11.3 11.7 11.7 9.9 11.9 11.0 10.5 10.3 10.130-39 14.6 13.7 13.5 13.4 13.4 12.9 12.3 12.8 12.0 12.540-49 16.5 15.4 15.1 15.1 13.6 13.0 13.3 13.7 14.4 13.250-59 19.0 18.4 18.0 18.0 16.4 17.5 16.7 16.4 16.7 15.960-64 20.2 20.1 19.9 19.7 18.1 19.2 18.1 19.0 18.4 18.365-69 21.3 20.1 21.0 19.8 19.6 19.6 19.1 18.0 18.8 18.270-79 21.9 21.2 20.1 21.1 20.2 19.6 19.0 19.0 19.5 16.880+ 26.5 21.2 21.0 18.4 18.3 17.5 19.0 18.9 19.5 18.0

0-19 13.9 16.2 14.6 12.2 12.4 13.5 12.5 10.9 13.1 11.820-44 14.6 13.3 13.5 13.4 12.7 12.9 12.3 12.4 12.3 12.045-64 18.9 18.5 18.0 17.9 16.3 16.8 16.3 16.6 16.8 16.065-74 21.4 20.5 20.6 20.3 20.0 19.5 19.1 18.2 19.3 17.375+ 23.9 21.1 20.1 20.2 19.1 18.9 18.8 19.4 19.0 17.8

Male 18.1 17.0 16.6 16.5 15.5 15.8 15.5 15.1 15.1 14.3Female 22.2 20.9 20.6 20.2 19.3 19.1 18.7 19.0 19.6 18.0



All 20.0 18.8 18.5 18.3 17.3 17.3 17.0 16.9 17.3 16.1

DIABETES0-19 * * * * . . * * * *20-29 22.5 19.3 18.3 18.2 17.1 16.3 19.2 17.7 19.9 18.830-39 23.3 21.0 20.8 20.1 20.5 18.9 19.1 19.6 18.3 19.340-49 24.0 21.6 21.2 21.3 19.7 18.2 18.7 19.6 19.3 18.450-59 25.2 23.9 22.5 22.8 20.5 21.9 21.1 20.8 21.1 20.160-64 23.7 23.0 22.9 23.3 20.5 22.0 21.0 22.3 22.1 21.165-69 24.6 22.9 23.9 23.2 23.0 23.0 22.4 21.4 22.5 21.170-79 26.9 25.6 23.6 25.4 23.9 23.1 23.0 22.3 22.6 19.880+ 39.2 24.0 24.8 19.4 21.5 21.6 23.7 22.9 23.7 23.5

0-19 * * * * . . * * * *20-44 23.5 20.6 20.7 20.3 19.5 18.6 18.8 18.8 18.3 18.945-64 24.4 23.4 22.3 22.6 20.4 21.1 20.6 21.3 21.3 20.165-74 25.3 24.0 23.9 24.1 23.5 23.0 22.8 21.8 22.9 20.275+ 31.4 24.8 23.5 23.7 22.7 23.1 23.0 22.7 21.7 22.0

Male 24.4 21.8 20.4 20.9 19.7 20.0 19.8 19.2 19.0 18.2Female 27.9 25.5 25.4 25.0 23.7 23.6 23.3 23.5 24.4 22.3



All 26.2 23.7 23.0 23.1 21.8 21.9 21.7 21.5 21.8 20.4

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.“.” Zero values in this cell.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.10.1 & E.10.2).


Table E.10 (continued)Hospital Days Per Patient Year: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.10.1 & E.10.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 12.0 17.2 16.7 12.3 9.6 7.3 * 9.2 7.9 6.620-29 12.1 10.8 11.2 11.9 7.8 10.0 7.3 7.5 9.3 9.130-39 11.7 12.0 11.7 11.6 12.2 10.4 9.7 11.3 9.8 9.140-49 12.8 13.6 13.0 12.7 11.2 10.9 11.2 10.3 12.3 9.850-59 13.6 13.9 14.2 13.6 13.2 14.2 13.6 13.0 13.9 12.760-64 16.4 18.8 16.8 15.8 15.3 16.2 14.8 16.1 15.3 14.665-69 18.3 18.4 18.2 16.0 17.0 16.9 16.7 15.0 15.5 14.970-79 18.6 18.7 17.7 17.7 18.2 17.2 16.5 16.7 18.5 14.880+ 24.1 21.6 19.7 17.7 17.0 16.4 17.3 17.3 19.0 15.1

0-19 12.0 17.2 16.7 12.3 9.6 7.3 * 9.2 7.9 6.520-44 11.6 11.7 11.8 11.9 11.4 10.9 10.0 10.3 10.7 9.345-64 14.6 15.6 14.8 14.1 13.1 13.6 13.1 12.9 13.6 12.365-74 17.9 18.3 18.0 16.4 17.6 16.7 16.4 15.3 16.9 14.675+ 21.7 20.2 18.3 18.3 17.6 17.2 16.9 17.7 18.8 15.4

Male 15.5 15.6 15.2 14.4 13.7 14.1 13.8 13.4 14.2 12.4Female 19.9 19.5 18.2 17.4 17.8 16.6 16.3 16.5 18.0 14.9



All 17.4 17.3 16.5 15.7 15.5 15.2 14.9 14.7 15.9 13.5


0-19 12.9 16.5 14.2 11.3 12.3 10.0 9.9 9.8 11.3 11.420-44 10.2 9.2 10.1 10.4 9.7 10.0 8.7 8.6 9.3 8.945-64 12.0 11.4 13.2 12.3 11.2 11.4 11.5 11.7 11.5 11.765-74 16.1 14.2 16.3 14.8 13.6 14.0 13.4 13.7 13.6 13.475+ 18.7 17.3 17.5 16.4 16.3 15.4 15.7 15.8 16.4 12.9

Male 12.3 11.4 12.6 12.0 11.5 11.6 11.2 10.9 11.2 10.4Female 13.9 12.7 14.0 13.5 12.2 12.2 11.6 12.4 12.7 12.4



All 12.9 11.9 13.1 12.6 11.8 11.9 11.4 11.5 11.8 11.2


Table E.10 (continued)Hospital Days Per Patient Year: CAPD/CCPD Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.10.1 & E.10.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 14.4 15.8 14.7 12.5 12.6 15.3 13.7 11.3 13.9 12.120-29 12.2 12.0 11.3 10.9 9.3 13.4 11.5 11.3 9.9 10.430-39 14.0 13.3 12.6 12.3 12.2 12.3 12.4 12.8 11.8 12.540-49 15.5 13.2 12.6 13.1 11.1 11.7 12.0 12.6 12.8 12.050-59 15.2 15.6 15.1 14.7 13.3 13.9 13.3 12.9 12.7 12.860-64 15.9 14.8 16.2 16.8 16.5 16.7 14.8 14.3 13.3 16.365-69 17.2 15.4 16.7 16.5 14.7 14.5 14.0 13.0 13.7 15.470-79 16.6 16.8 16.9 18.6 16.6 17.2 14.8 16.0 14.9 14.180+ 16.7 17.9 20.4 19.5 17.5 15.3 17.3 18.4 15.7 18.8

0-19 14.5 15.8 14.7 12.5 12.6 15.3 13.7 11.3 13.9 12.120-44 13.8 12.6 12.2 12.1 11.1 12.6 12.1 12.3 11.4 11.545-64 15.6 15.1 14.8 14.9 13.4 13.7 13.1 13.0 12.9 13.565-74 16.8 15.8 16.6 17.5 15.5 15.7 14.3 13.8 14.2 14.075+ 16.8 17.7 18.7 19.0 16.9 16.4 15.9 18.2 15.2 17.3

Male 14.8 14.2 14.4 14.6 13.0 13.4 12.8 13.0 12.2 12.8Female 16.5 16.3 16.4 16.5 15.2 15.7 15.0 15.2 14.6 15.1



All 15.6 15.2 15.4 15.5 14.1 14.5 13.8 14.0 13.4 13.9


Table E.11Hospital Days Per Patient Year: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

ALL 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 6.4 5.7 6.1 5.6 5.2 6.1 5.3 5.9 5.9 6.020-29 6.3 5.7 5.7 4.6 4.9 5.3 4.8 4.7 5.0 5.030-39 7.0 7.1 5.6 5.5 5.2 5.0 5.4 5.4 5.6 5.840-49 8.5 8.0 6.5 6.3 6.3 6.0 6.1 6.1 6.3 6.350-59 9.6 8.9 8.9 7.9 7.9 7.0 6.6 7.3 7.1 6.860-64 8.5 9.4 7.8 9.0 8.9 8.3 8.1 8.0 8.6 8.465+ 9.4 9.8 9.7 7.7 8.2 7.6 8.7 7.4 9.0 8.7

0-19 6.4 5.7 6.1 5.6 5.2 6.1 5.3 5.9 5.9 6.020-44 7.2 6.9 6.0 5.6 5.5 5.4 5.4 5.4 5.5 5.745-64 9.5 9.2 8.0 7.6 7.6 7.0 6.9 7.2 7.5 7.165+ 9.4 9.8 9.7 7.7 8.2 7.6 8.7 7.4 9.0 8.7

Male 9.0 9.3 8.4 7.2 7.3 6.8 7.2 6.6 7.1 6.9Female 8.9 8.7 8.7 7.7 8.0 7.5 7.9 7.5 8.8 8.5

White 9.1 8.7 8.0 7.0 7.2 6.8 7.0 6.5 7.5 7.1Black 8.9 9.7 9.6 8.4 8.4 7.7 8.4 7.9 8.7 8.8Other race 7.6 8.2 6.5 5.6 7.5 5.5 8.5 6.0 6.7 6.1


All 9.0 9.0 8.5 7.4 7.6 7.1 7.6 7.0 7.9 7.7

DIABETES0-19 * * * * * * * * * *20-29 13.2 11.4 10.8 9.2 9.9 10.6 9.3 8.2 11.0 11.330-39 12.2 12.4 9.6 9.0 8.4 7.9 8.9 9.2 9.4 9.640-49 13.3 12.6 10.3 9.7 9.3 8.8 8.9 8.1 9.2 9.350-59 12.5 11.9 12.1 10.9 10.3 9.1 8.8 9.3 8.9 8.460-64 10.0 11.3 9.4 10.8 10.4 9.9 9.9 9.7 10.1 9.365+ 13.1 11.9 12.1 9.6 9.4 7.9 9.4 8.9 11.2 11.2

0-19 * * * * * * * * * *20-44 12.3 11.9 10.2 9.7 9.2 8.7 8.8 8.5 9.1 9.745-64 12.6 12.5 10.8 10.1 9.8 9.0 9.2 9.2 9.5 8.865+ 13.0 11.8 12.1 9.7 9.4 7.9 9.4 8.8 11.2 11.2

Male 13.0 12.5 11.5 10.2 9.7 8.4 8.8 8.6 9.3 9.2Female 12.1 11.4 11.4 9.8 9.5 8.6 9.7 9.3 11.3 11.0



All 12.6 11.9 11.4 10.0 9.6 8.5 9.2 9.0 10.3 10.1

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data on the Medical Evidence form in April 1995. Because the model-based adjustment method usesdata from the current & previous two years, rates for Hispanic patients are shown only for 1998 & later.*Values for cells with 10 or fewer patients are suppressed.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.11.1 & E.11.2).


Table E.11 (continued)Hospital Days Per Patient Year: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1998 have therefore been left blank.*Values for cells with 10 or fewer patients are suppressed.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.11.1 & E.11.2).

HYPERTENSION 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 7.0 4.7 7.4 6.5 6.2 4.7 5.7 6.6 5.1 *20-29 8.1 5.9 6.0 4.3 5.0 4.9 3.8 3.5 4.5 3.630-39 6.2 6.0 4.4 5.0 4.8 4.5 4.5 4.6 4.7 5.140-49 7.7 6.7 4.6 5.2 5.6 5.5 5.6 5.5 5.8 5.750-59 7.9 6.4 6.3 5.2 6.4 5.7 5.0 5.9 6.4 6.360-64 6.8 8.1 6.7 8.3 8.3 7.0 6.3 5.9 7.1 8.965+ 6.5 7.9 7.3 6.4 8.0 8.2 8.4 6.1 7.7 7.0

0-19 7.0 4.7 7.4 6.6 6.2 4.7 5.7 6.6 5.1 *20-44 6.9 6.0 4.9 4.9 5.2 5.0 4.6 4.6 4.8 5.145-64 7.9 7.0 5.8 5.7 6.5 5.9 5.5 5.9 6.6 6.665+ 6.5 7.9 7.3 6.4 8.0 8.2 8.4 6.1 7.7 7.0

Male 7.2 8.0 6.8 5.8 6.8 6.9 7.0 5.4 6.5 6.3Female 6.4 6.6 6.3 6.5 7.9 7.4 7.2 6.4 7.6 7.2



All 6.9 7.4 6.6 6.1 7.3 7.1 7.0 5.8 7.0 6.7

GLOMERULONEPHRITIS0-19 6.6 6.8 6.3 6.7 5.2 6.1 4.9 6.4 6.0 6.320-29 5.2 4.7 4.8 3.8 4.1 4.0 3.6 4.2 3.9 4.230-39 4.7 4.9 3.9 3.6 3.6 3.3 3.2 3.9 3.8 3.840-49 5.5 5.3 4.9 4.0 4.3 3.8 3.4 4.5 4.5 3.950-59 6.8 6.5 5.9 5.5 5.1 4.3 3.8 5.2 4.9 4.860-64 6.8 5.8 4.8 5.5 6.5 5.2 5.2 5.0 5.7 5.165+ 7.1 8.1 7.4 7.0 6.8 6.0 6.9 6.4 6.0 6.0

0-19 6.6 6.8 6.3 6.7 5.2 6.2 4.9 6.4 6.0 6.320-44 5.1 4.9 4.5 3.8 3.9 3.7 3.3 4.1 3.9 3.945-64 6.3 6.0 5.1 4.9 5.2 4.3 4.0 5.0 5.1 4.665+ 7.1 8.1 7.4 6.9 6.8 6.1 6.9 6.3 6.1 6.0

Male 5.8 6.1 5.4 4.8 5.0 4.4 4.6 5.2 4.7 4.6Female 6.7 6.6 6.1 5.8 5.6 5.0 4.7 5.0 5.4 5.1



All 6.2 6.3 5.7 5.2 5.2 4.6 4.6 5.1 5.0 4.8


Table E.11 (continued)Hospital Days Per Patient Year: Transplant Patients, by Primary Diagnosis, Adjustedperiod prevalent patients, including all hospitalizations from Part A institutional inpatient claims

Overall rates are adjusted for age, gender, race, & primary diagnosis. Rates presented by one of these variables are adjusted for the remaining three.ESRD cohort from 2002 used as reference.Includes all patients who have reached day 91 of ESRD by December 31 of each calendar year.Patient age is determined on January 1 of each calendar year.†CMS began collecting Hispanic ethnicity data in April 1995; cells for years prior to 1998 have therefore been left blank.On our website: Hospital Days per Patient, & Counts of Total Hospital Days, Years at Risk, & Total Patients (Tables E.11.1 & E.11.2).

OTHER 1993 1994 1995 1996 1997 1998 1999 2000 2001 20020-19 6.3 5.3 6.1 5.0 5.2 6.1 5.5 5.7 5.8 6.020-29 4.8 5.1 4.9 4.3 4.3 5.0 5.1 4.6 4.7 4.530-39 5.4 5.5 4.8 4.6 4.3 4.5 5.1 4.2 4.6 4.940-49 5.8 5.7 5.2 5.0 4.7 4.9 5.3 5.4 4.7 5.050-59 6.3 6.3 6.1 5.7 5.8 5.2 4.8 5.4 5.0 5.060-64 6.5 6.4 5.3 5.4 5.4 5.9 5.8 6.1 6.4 5.865+ 6.7 8.8 9.2 5.6 6.3 6.4 8.6 6.6 7.1 6.7

0-19 6.3 5.3 6.1 5.0 5.2 6.1 5.5 5.7 5.8 6.020-44 5.3 5.3 4.9 4.6 4.3 4.8 5.1 4.7 4.6 4.745-64 6.1 6.2 5.7 5.4 5.4 5.3 5.2 5.4 5.2 5.165+ 6.7 8.8 9.2 5.6 6.3 6.4 8.6 6.6 7.1 6.7

Male 6.4 7.4 7.0 5.3 5.1 5.3 6.4 5.5 5.5 5.4Female 6.0 6.6 6.9 5.3 5.9 6.1 6.7 6.0 6.4 6.1



All 6.2 7.0 6.9 5.3 5.5 5.6 6.6 5.8 5.9 5.7

442M

orbid

ity & h

ospita

lizationh

Table E.12Total Hospital Discharges: by General Diagnostic Related Groupperiod prevalent patients

One DRG per discharge. *Values for cells with 10 or fewer discharges are suppressed. On our website: Total Hospital Discharges, by Detailed Diagnostic Related Group (E.12.1).

1998 1999 2000 2001 2002ALL Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure AllNervous 22,581 2,906 25,487 23,410 2,920 26,330 24,341 3,059 27,400 26,086 3,375 29,461 27,139 3,678 30,817Eye 291 463 754 295 379 674 394 335 729 343 283 626 383 287 670Ear, nose, & throat 1,733 269 2,002 2,093 232 2,325 2,057 237 2,294 1,997 255 2,252 2,367 268 2,635Respiratory 35,358 1,694 37,052 38,957 1,842 40,799 39,103 2,268 41,371 41,944 2,546 44,490 46,073 2,881 48,954Circulatory 101,582 80,378 181,960 109,122 81,420 190,542 116,302 82,362 198,664 128,304 82,042 210,346 136,413 74,821 211,234Gastrointestinal 31,782 8,024 39,806 32,384 7,840 40,224 34,168 7,837 42,005 37,229 8,294 45,523 39,834 8,441 48,275Hepatic 6,809 2,954 9,763 7,058 3,017 10,075 7,293 3,186 10,479 7,985 3,404 11,389 8,923 3,574 12,497Muscular/skeletal 9,479 10,616 20,095 10,559 11,265 21,824 11,196 12,021 23,217 12,409 13,370 25,779 12,933 14,227 27,160Skin/breast 6,435 3,119 9,554 7,237 3,272 10,509 8,077 3,360 11,437 8,736 3,632 12,368 9,434 3,746 13,180Endocrine 18,484 4,072 22,556 19,792 4,375 24,167 21,336 4,468 25,804 23,941 5,342 29,283 27,679 5,691 33,370Renal 50,907 28,660 79,567 53,425 27,974 81,399 57,592 28,561 86,153 61,955 29,960 91,915 64,741 30,132 94,873Male reproductive 361 694 1,055 352 715 1,067 425 762 1,187 424 721 1,145 469 772 1,241Female reproductive 391 856 1,247 419 775 1,194 498 889 1,387 500 967 1,467 557 1,057 1,614Pregnancy 156 81 237 200 82 282 163 91 254 148 73 221 151 74 225Hematologic 4,032 252 4,284 4,131 229 4,360 4,542 235 4,777 5,422 270 5,692 6,056 278 6,334Myeloproliferative 1,392 327 1,719 1,403 336 1,739 1,448 369 1,817 1,578 378 1,956 1,733 439 2,172Infection 22,305 5,732 28,037 22,293 5,250 27,543 22,207 5,300 27,507 23,940 5,627 29,567 27,138 5,967 33,105Psychological 5,335 282 5,617 5,634 276 5,910 5,606 230 5,836 5,565 257 5,822 5,681 237 5,918Injury/poisoning 6,745 4,644 11,389 7,153 4,561 11,714 7,474 4,503 11,977 7,900 4,833 12,733 7,809 4,751 12,560Burns 58 66 124 * * * * * * * * * * * *Other factors 12,169 1,034 13,203 14,572 1,169 15,741 15,759 1,272 17,031 15,928 1,323 17,251 15,854 1,262 17,116Unclassifed * 3,750 3,750 * 4,835 4,835 * 5,100 5,100 * 5,548 5,548 * 6,029 6,029HIV 1,700 176 1,876 1,910 199 2,109 2,115 210 2,325 2,159 232 2,391 2,146 227 2,373

All 340,085 161,049 501,134 362,399 162,965 525,364 382,096 166,659 548,755 414,493 172,735 587,228 443,513 168,839 612,352

DIALYSISNervous 18,462 2,231 20,693 18,989 2,324 21,313 19,715 2,404 22,119 20,794 2,625 23,419 21,771 2,908 24,679Eye 218 363 581 217 299 516 281 275 556 265 223 488 292 212 504Ear, nose, & throat 1,105 182 1,287 1,306 141 1,447 1,415 146 1,561 1,326 152 1,478 1,593 163 1,756Respiratory 29,058 1,248 30,306 31,588 1,370 32,958 31,803 1,763 33,566 33,775 1,955 35,730 37,284 2,230 39,514Circulatory 86,381 70,373 156,754 93,735 71,439 165,174 99,338 71,955 171,293 108,921 71,033 179,954 116,654 65,636 182,290Gastrointestinal 25,657 6,297 31,954 25,748 6,134 31,882 26,862 6,063 32,925 29,169 6,296 35,465 31,194 6,390 37,584Hepatic 5,067 2,133 7,200 5,155 2,176 7,331 5,261 2,190 7,451 5,850 2,344 8,194 6,564 2,567 9,131Muscular/skeletal 7,518 7,764 15,282 8,393 8,435 16,828 9,020 8,997 18,017 9,801 9,875 19,676 10,274 10,666 20,940Skin/breast 4,698 2,398 7,096 5,385 2,549 7,934 6,069 2,620 8,689 6,548 2,763 9,311 7,131 2,897 10,028Endocrine 13,493 3,192 16,685 14,476 3,451 17,927 15,615 3,413 19,028 17,407 4,130 21,537 20,469 4,453 24,922Renal 36,836 16,222 53,058 39,039 15,929 54,968 41,815 16,063 57,878 44,759 16,175 60,934 46,853 16,300 63,153Male reproductive 253 494 747 234 503 737 287 500 787 302 497 799 333 511 844Female reproductive 274 552 826 296 475 771 360 545 905 368 605 973 392 657 1,049Pregnancy 64 24 88 85 34 119 78 36 114 69 34 103 80 32 112Hematologic 3,059 115 3,174 3,089 125 3,214 3,332 115 3,447 4,022 157 4,179 4,487 158 4,645Myeloproliferative 1,035 226 1,261 1,060 216 1,276 1,080 237 1,317 1,166 230 1,396 1,310 292 1,602Infection 17,338 4,653 21,991 17,321 4,276 21,597 17,225 4,218 21,443 18,331 4,428 22,759 20,999 4,674 25,673Psychological 4,353 257 4,610 4,572 239 4,811 4,476 210 4,686 4,398 222 4,620 4,446 217 4,663Injury/poisoning 5,546 3,742 9,288 5,797 3,690 9,487 5,980 3,588 9,568 6,263 3,742 10,005 6,255 3,749 10,004Burns 40 49 89 * * * * * * * * * * * *Other factors 10,146 910 11,056 12,129 1,009 13,138 13,170 1,076 14,246 12,936 1,128 14,064 12,999 1,040 14,039Unclassifed * 2,986 2,986 * 3,770 3,770 * 3,978 3,978 * 4,282 4,282 * 4,785 4,785HIV 1,564 164 1,728 1,716 187 1,903 1,946 190 2,136 2,012 206 2,218 1,969 198 2,167

All 272,165 126,575 398,740 290,330 128,773 419,103 305,128 130,584 435,712 328,482 133,104 461,586 353,349 130,735 484,084

443H

2004 USR

DS A

nn

ua

l Data

Repo

rt

Table E.12 (continued)Total Hospital Discharges: by General Diagnostic Related Groupperiod prevalent patients

One DRG per discharge. *Values for cells with10 or fewer discharges are suppressed. On our website: Total Hospital Discharges, by Detailed Diagnostic Related Group (E.12.1).

1998 1999 2000 2001 2002HEMODIALYSIS Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure AllNervous 15,716 1,911 17,627 16,482 2,076 18,558 17,393 2,139 19,532 18,434 2,346 20,780 19,433 2,614 22,047Eye 188 326 514 190 259 449 253 255 508 239 205 444 263 195 458Ear, nose, & throat 986 155 1,141 1,172 126 1,298 1,305 139 1,444 1,201 133 1,334 1,471 149 1,620Respiratory 26,242 1,114 27,356 28,835 1,235 30,070 29,163 1,610 30,773 31,272 1,825 33,097 34,751 2,089 36,840Circulatory 76,902 64,493 141,395 84,938 66,253 151,191 90,592 66,977 157,569 100,244 66,527 166,771 108,276 61,821 170,097Gastrointestinal 19,899 4,860 24,759 20,922 4,924 25,846 22,120 4,932 27,052 24,469 5,193 29,662 26,494 5,350 31,844Hepatic 4,287 1,830 6,117 4,554 1,903 6,457 4,645 1,918 6,563 5,171 2,088 7,259 5,805 2,302 8,107Muscular/skeletal 6,794 6,976 13,770 7,671 7,714 15,385 8,266 8,285 16,551 9,072 9,103 18,175 9,513 9,894 19,407Skin/breast 4,200 2,144 6,344 4,858 2,277 7,135 5,481 2,349 7,830 5,959 2,543 8,502 6,595 2,678 9,273Endocrine 11,082 2,838 13,920 12,291 3,047 15,338 13,407 3,092 16,499 15,141 3,747 18,888 18,135 4,090 22,225Renal 31,345 13,169 44,514 33,823 13,136 46,959 36,497 13,515 50,012 39,385 13,843 53,228 41,798 14,110 55,908Male reproductive 210 430 640 200 441 641 254 444 698 268 455 723 293 457 750Female reproductive 229 449 678 256 416 672 310 472 782 322 531 853 346 584 930Pregnancy 57 22 79 79 31 110 72 34 106 62 29 91 77 28 105Hematologic 2,612 105 2,717 2,662 116 2,778 2,876 97 2,973 3,488 149 3,637 3,928 147 4,075Myeloproliferative 870 198 1,068 884 188 1,072 921 208 1,129 999 202 1,201 1,152 254 1,406Infection 15,189 4,134 19,323 15,496 3,821 19,317 15,540 3,804 19,344 16,561 4,031 20,592 18,805 4,238 23,043Psychological 3,901 227 4,128 4,190 208 4,398 4,090 197 4,287 4,076 203 4,279 4,121 201 4,322Injury/poisoning 2,869 1,747 4,616 3,147 1,777 4,924 3,407 1,840 5,247 3,756 2,053 5,809 4,018 2,086 6,104Burns 36 45 81 * * * * * * * * * * * *Other factors 8,797 799 9,596 10,671 887 11,558 11,669 948 12,617 11,504 1,004 12,508 11,792 932 12,724Unclassifed * 2,531 2,531 * 3,245 3,245 * 3,475 3,475 * 3,768 3,768 * 4,207 4,207HIV 1,390 139 1,529 1,532 155 1,687 1,788 167 1,955 1,874 185 2,059 1,796 183 1,979

All 233,801 110,642 344,443 254,853 114,237 369,090 270,049 116,899 386,948 293,497 120,165 413,662 318,862 118,609 437,471

PERITONEAL DIALYSISNervous 2,045 223 2,268 1,755 177 1,932 1,605 202 1,807 1,640 205 1,845 1,668 203 1,871Eye 23 27 50 20 27 47 19 17 36 21 14 35 26 12 38Ear, nose, & throat 94 19 113 108 12 120 87 * 91 100 14 114 95 13 108Respiratory 1,773 79 1,852 1,699 72 1,771 1,554 92 1,646 1,395 80 1,475 1,505 78 1,583Circulatory 5,776 3,535 9,311 4,998 3,077 8,075 4,838 2,918 7,756 4,838 2,679 7,517 4,735 2,184 6,919Gastrointestinal 4,888 1,150 6,038 3,927 938 4,865 3,860 893 4,753 3,803 855 4,658 3,853 828 4,681Hepatic 599 244 843 446 209 655 443 208 651 478 181 659 542 195 737Muscular/skeletal 521 596 1,117 490 542 1,032 463 497 960 469 553 1,022 499 557 1,056Skin/breast 372 194 566 353 197 550 383 204 587 402 147 549 384 151 535Endocrine 1,923 266 2,189 1,646 305 1,951 1,645 234 1,879 1,725 291 2,016 1,827 271 2,098Renal 2,733 1,107 3,840 2,346 993 3,339 2,257 929 3,186 2,330 837 3,167 2,213 797 3,010Male reproductive 34 40 74 25 38 63 22 28 50 24 27 51 29 31 60Female reproductive 37 81 118 33 53 86 33 63 96 30 57 87 29 61 90Pregnancy * * * * * * * * * * * 11 * * *Hematologic 320 * 329 300 * 306 299 10 309 379 * 385 391 * 399Myeloproliferative 42 10 52 50 * 55 66 12 78 35 * 44 44 11 55Infection 1,456 339 1,795 1,114 272 1,386 1,011 266 1,277 1,052 257 1,309 1,444 281 1,725Psychological 332 20 352 242 22 264 242 * 248 213 12 225 231 * 239Injury/poisoning 2,410 1,783 4,193 2,377 1,695 4,072 2,265 1,513 3,778 2,208 1,485 3,693 1,967 1,478 3,445Burns * * * * * * * * * * * * * * *Other factors 891 65 956 836 64 900 878 68 946 890 56 946 726 68 794Unclassifed * 318 318 * 339 339 * 332 332 * 338 338 * 373 373HIV 129 16 145 132 13 145 116 11 127 88 13 101 118 * 125

All 26,405 10,126 36,531 22,903 9,059 31,962 22,092 8,509 30,601 22,127 8,120 30,247 22,328 7,618 29,946

444M

orbid

ity & h

ospita

lizationh

Table E.12 (continued)Total Hospital Discharges: by General Diagnostic Related Groupperiod prevalent patients

One DRG per discharge.*Values for cells with 10 or fewer discharges are suppressed.On our website: Total Hospital Discharges, by Detailed Diagnostic Related Group (E.12.1).

1998 1999 2000 2001 2002TRANSPLANT Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure All Medical Procedure AllNervous 1,680 272 1,952 1,689 238 1,927 1,892 287 2,179 2,039 291 2,330 2,082 267 2,349Eye 38 45 83 48 42 90 51 37 88 41 32 73 41 38 79Ear, nose, & throat 358 55 413 465 59 524 365 59 424 369 68 437 453 68 521Respiratory 2,732 213 2,945 3,308 230 3,538 3,232 243 3,475 3,483 277 3,760 3,747 327 4,074Circulatory 4,518 2,493 7,011 4,679 2,417 7,096 5,067 2,538 7,605 5,559 2,489 8,048 5,784 2,056 7,840Gastrointestinal 2,405 726 3,131 2,608 688 3,296 2,942 737 3,679 3,287 819 4,106 3,579 868 4,447Hepatic 908 431 1,339 955 422 1,377 1,001 493 1,494 1,021 497 1,518 1,119 462 1,581Muscular/skeletal 947 1,540 2,487 1,085 1,443 2,528 1,037 1,578 2,615 1,232 1,740 2,972 1,200 1,764 2,964Skin/breast 991 363 1,354 1,020 381 1,401 1,146 380 1,526 1,157 430 1,587 1,190 404 1,594Endocrine 2,529 414 2,943 2,620 420 3,040 2,741 503 3,244 3,039 546 3,585 3,393 565 3,958Renal 6,421 2,059 8,480 6,670 2,056 8,726 7,405 2,200 9,605 8,123 2,315 10,438 8,530 2,243 10,773Male reproductive 50 88 138 58 102 160 60 129 189 53 88 141 56 115 171Female reproductive 84 187 271 60 184 244 74 215 289 63 211 274 91 238 329Pregnancy 66 41 107 80 36 116 57 29 86 46 22 68 48 28 76Hematologic 427 31 458 431 29 460 531 51 582 597 38 635 678 44 722Myeloproliferative 179 62 241 139 77 216 182 70 252 166 91 257 177 89 266Infection 2,185 405 2,590 2,176 349 2,525 2,226 372 2,598 2,311 410 2,721 2,570 446 3,016Psychological 431 * 434 448 * 452 505 * 509 451 10 461 486 * 491Injury/poisoning 333 215 548 385 189 574 451 231 682 450 284 734 444 282 726Burns 11 10 21 * * * * * * * * * * * *Other factors 882 38 920 987 51 1,038 1,059 65 1,124 1,134 57 1,191 1,110 64 1,174Unclassifed * 311 311 * 427 427 * 476 476 * 505 505 * 489 489HIV * * * * * * * * * * * 11 * * *

All 28,183 10,002 38,185 29,915 9,844 39,759 32,024 10,697 42,721 34,628 11,224 45,852 36,783 10,862 47,645

e - morbidity & hospitalization410 morbidity & hospitalizationh table e.1 · 411 total...

Documents